| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Differential diagnosis of ulcers throughout the colon. | Deesomsak, M Sukeepaisarnjaroen, W Sawanyawisuth, K |
0 | ||||
| 2. | Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding. | Sukeepaisarnjaroen, W Sawanyawisuth, K |
0 | ||||
| 3. | GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis. | Chunlertrith, K Noiprasit, A Foocharoen, C Mairiang, P Sukeepaisarnjaroen, W Sangchan, A Sawadpanitch, K |
0 | ||||
| 4. | Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy. | Sukeepaisarncharoen, W Churdboonchart, V Kulpradist, S Isarangkura Na Ayudthya, B Rugpao, S Chandeying, V Sirawaraporn, W Carlo, D Moss, RB |
0 | ||||
| 5. | Etiology of dyspepsia in Srinagarind Hospital : a prospective data analysis | Kitti Chunlertrith Pisaln Mairiang Wattana Sukeepaisarnjaroen Eimorn Mairiang Vallop Laopaiboon |
1990 | ||||
| 6. | Intestinal capillariasis: a cause of chronic diarrhea and hypoalbuminemia. | Chunlertrith, K. Mairiang, P. Sukeepaisarnjaroen, W. |
1992 | ||||
| 7. | The study of discriminant values of dyspeptic symptoms for identifying the etiology of dyspepsia. | Chunlertrith, K Sukeepaisarnjaroen, W Mairiang, E Laopaiboon, V Pairojkul, C Bhudhisawasdi, V |
1992 | ||||
| 8. | Burkholder meningitis. | Chotmongkol, V Sukeepaisarncharoen, W |
1996 | ||||
| 9. | Comparison of adult somatic and excretory-secretory antigens in enzyme-linked immunosorbent assay for serodiagnosis of human infection with Fasciola gigantica | Maleewong, W Intapan, PM Wongkham, C Tomanakan, K Daenseekaew, W Sukeepaisarnjaroen, W |
1996 | ||||
| 10. | Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. | Chotmongkol, V Sukeepaisarncharoen, W Thavornpitak, Y |
1997 | ||||
| 11. | Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. | Chotmongkol, V Sukeepaisarncharoen, W |
1997 | ||||
| 12. | A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected thai subjects with CD4-cell counts of >300. | Churdboonchart, V Sakondhavat, C Kulpradist, S Na Ayudthya, BI Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R |
2000 | ||||
| 13. | Clinico-epidemiology of hepatitis B viral infection in Northeastern Thailand | Chunlertrith, K Sukeepaisarnjaroen, W Mairiang, P Urwijitaroon, Y Takase, K Yamauchi, T Yoshimura, H Tameda, Y |
2000 | ||||
| 14. | Clinico-epidemiology of hepatitis C viral infection in northeastern Thailand. | Chunlertrith, K. Sukeepaisarnjaroen, W. Mairiang, P. Urwijitaroon, Y. Takase, K. Yamauchi, T. Yoshimura, H. Tameda, Y. |
2000 | ||||
| 15. | A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000) | V Churdboonchart C Sakondhavat S Kulpradist BIN Ayudthya V Chandeying S Rugpao C Boonshuyar W Sukeepaisarncharoen W Sirawaraporn DJ Carlo R Moss |
2001 | ||||
| 16. | Effectiveness of remune - Authors' reply | V Churdboonchart W Sirawaraporn C Boonshuyar C Sakondhavat W Sukeepaisarncharoen S Kulpradist BIN Ayudthya V Chandeying S Rugpao |
2001 | ||||
| 17. | Delayed progression to AIDS in volunteers treated with long-term HIV-1 immunogen (REMUNE (R)) therapy in Thailand | W Chantratita W Sukeepaisarncharoen V Chandeying S Kulpradist BIN Ayudhtaya S Rugpao W Sirawaraporn C Boonshuyar V Churdboonchart |
2004 | ||||
| 18. | Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand. | Chantratita, W Sukeepaisarncharoen, W Chandeying, V Kulpradist, S Israngkura Na Ayudhtaya, B Rugpao, S Sirawaraporn, W Boonshuyar, C Churdboonchart, V |
2004 | ||||
| 19. | Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis | Intapan, PM Maleewong, W Sukeepaisarnjaroen, W Morakote, N |
2006 | ||||
| 20. | The endoscopic-pathologic findings in intestinal capillariais: A case report | Sangchan, A Wongsaensook, A Kularbkaew, C Sawanyawisuth, K Sukeepaisarnjaroen, W Mairiang, P |
2007 | ||||
| 21. | An enzyme-linked immunosorbent assay as screening tool for human intestinal capillariasis | Pewpan M. Intapan Wanchai Maleewong Watana Sukeepaisarnjaroen Nimit Morakote |
2010 | ||||
| 22. | Biliary Ascariasis After Worm Removal from the Duodenum and Single-Dose Albendazole Treatment | Wongsaensook, A Sukeepaisarnjaroen, W Sawanyawisuth, K |
2010 | ||||
| 23. | Images in clinical tropical medicine: Biliary ascariasis after worm removal from the duodenum and single-dose albendazole treatment | Wongsaensook, A. Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2010 | ||||
| 24. | RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY | G. Foster R. Flisiak W. -L. Chuang J. George J. Rasenack A. Sood P. Komolmit S. Thongsawat T. Tanwandee R. Sola W. Sukeepaisarnjaroen M. Weltman Y. Yin G. Feutren K. Brown |
2011 | ||||
| 25. | 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS | T. Piratvisuth P. Komolmit T. Tanwandee W. Sukeepaisarnjaroen H. L. Chan M. G. Pessoa E. Fassio S. Ono-Nita F. Bessone J. Daruich S. Zeuzem H. Cheinquer Y. Dong A. Trylesinski |
2012 | ||||
| 26. | A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). | Thomas Cheung Yau Wattana Sukeepaisarnjaroen Yee Chao Chia-Jui Yen Wirote Lausoontornsiri Pei-Jer Chen Theeranun Sanpajit Riccardo Lencioni Aaron C. Camp Donna S. Cox Howard Kallender Lone Harild Ottesen Ronnie Tung-Ping Poon |
2012 | ||||
| 27. | Hospitalized incidence and outcomes of upper gastrointestinal bleeding in Thailand. | Sangchan, A. Sawadpanitch, K. Mairiang, P. Chunlertrith, K. Sukeepaisarnjaroen, W. Sutra, S. Thavornpitak, Y. |
2012 | ||||
| 28. | Significant clinical risks and the benefits of liver biopsies in Srinagarind Hospital, Khon Kaen University, Thailand: Lessons learned from the past to the present | Wongsaensook, A. Sukeepaisarnjaroen, W. Sukeepaisarnjaroen, W. Kularbkaew, C. |
2012 | ||||
| 29. | 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B. | Sukeepaisarnjaroen, W. Chan, H.L. Ono, S. |
2013 | ||||
| 30. | Sonographic findings of hepatocellular carcinoma detected in ultrasound surveillance of cirrhotic patients | Chamadol, N Somsap, K Laopaiboon, V Sukeepaisarnjaroen, W |
2013 | ||||
| 31. | Differential diagnosis of ulcers throughout the colon | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2014 | ||||
| 32. | Final results of Boceprevir Early-Access For Advanced Fibrosis/Cirrhosis In Asia-Pacific HCV Genotype 1 Non-Responders/Relapser Patients (Beacon Study) | Wattana Sukeepaisarnjaroen Tri H. Pham Tawesak Tanwandee Saroja Nazareth Sam Galhenage Lindsay Mollison Leanne Totten Alan J. Wigg Rosalie Altus Anton Colman Brenda Morales Susan Mason Tracey L. Jones Nadine Leembruggen Vince Fragomelli Cheryl Sendall Richard Guan Dede Sutedja Soek Siam Tan Yock Young Dan Yin-Mei Lee Widjaja Luman Eng Kiong Teo Yin Min Than Teerha Piratvisuth Seng Gee Lim |
2014 | ||||
| 33. | Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2014 | ||||
| 34. | Genetic Variation in Vitamin D Pathway DHCR7 Gene Predicts Poor Response to Pegylated Interferon-Alfa Based Therapy in Asian Chronic Hepatitis C Genotype 1-Infected Patients | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Panarat Thaimai Warattaya Sukkharin Srunthron Akkarathamrongsin Yong Poovorawan Pinit Kullavanijaya Piyawat Komolmit |
2014 | ||||
| 35. | GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis | K. Chunlertrith A. Noiprasit C. Foocharoen P. Mairiang W. Sukeepaisarnjaroen A. Sangchan K. Sawadpanitch |
2014 | ||||
| 36. | The Association of the CXCL10, Dpp-4 Gene Polymorphisms and Complementary Role for Unfavorable IL-28B Genotype in Prediction of Treatment Response in Asian Patients With Chronic Hepatitis C Virus Infection | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Panarat Thaimai Warattaya Sukkharin Srunthron Akkarathamrongsin Yong Poovorawan Pinit Kullavanijaya Piyawat Komolmit |
2014 | ||||
| 37. | VITAMIN D RELATED PATHWAY GENE POLYMORPHISMS ENHANCED THE PREDICTION OF TREATMENT RESPONSE IN ASIAN CHRONIC HEPATITIS C-INFECTED PATIENTS WITH UNFAVORABLE IL-28B rs12979860 GENOTYPES | K. Thanapirom S. Suksawatamnuay W. Sukeepaisarnjaroen P. Tangkijvanich S. Treeprasertsuk P. Thaimai S. Akkarathamrongsin Y. Poovorawan P. Kullavanijaya P. Komolmit |
2014 | ||||
| 38. | Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. | Sukeepaisarnjaroen, W. Wasitthankasem, R. Poovorawan, Y. |
2015 | ||||
| 39. | Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers | Sukeepaisarnjaroen, W Pham, T Tanwandee, T Nazareth, S Galhenage, S Mollison, L Totten, L Wigg, A Altus, R Colman, A Morales, B Mason, S Jones, T Leembruggen, N Fragomelli, V Sendall, C Guan, R Sutedja, D Tan, SS Dan, YY Lee, YM Luman, W Teo, EK Than, YM Piratvisuth, T Lim, SG |
2015 | ||||
| 40. | Genetic Variation in Vitamin D Pathway CYP2R1 gene predict sustained HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon: Multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Kittiyod Poovorawan Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 | ||||
| 41. | Phase II study of front-line dovitinib (TKI258) versus sorafenib in patients (Pts) with advanced hepatocellular carcinoma (HCC) | Ann-Lii Cheng Sumitra Thongprasert Ho Yeong Lim Wattana Sukeepaisarnjaroen Tsai-Sheng Yang Cheng-Chung Wu Yee Chao Stephen Lam Chan Masatoshi Kudo Masafumi Ikeda Yoon-Koo Kang Hongming Pan Kazushi Numata Guohong Han Binaifer Balsara Yong Zhang Ana-Maria Rodriguez Yi Zhang Yongyu Wang Ronnie Tung-Ping Poon |
2015 | ||||
| 42. | The Association of vitamin D metabolic pathway related genes polymorphisms with virologic response in HBeAg-negative patients treated with pegylated interferon: Multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 | ||||
| 43. | The Single Nucleotide Polymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B Patients Treated With Pegylated Interferon: Multicenter Study | Kessarin Thanapirom Sirinporn Suksawatamnuay Kittiyod Poovorawan Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Apinya Leerapun Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 | ||||
| 44. | A phase (Ph) II study of the efficacy and safety of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced hepatocellular carcinoma (HCC) | Tawesak Tanwandee Wattana Sukeepaisarnjaroen Stephen Lam Chan SuPin Choo Guohong Han Virote Sriuranpong Hongming Pan Thomas Cheung Yau Zhenggang Ren Jian-Ming Xu Bin Peng Takami Saji Yongjian Sun Alan Huang Luigi Manenti Shukui Qin |
2016 | ||||
| 45. | Cost utility analysis of palliative biliary drainage compare with palliative care in unresectable hilar cholangiocarcinoma | Schlermbhol Borntrakulpipat Apichat Sangchan Pisaln Mairiang Eimorn Mairiang Wattana Sukeepaisarnjaroen Kitti Chunlertrith Kookwan Sawadpanitch Tanita Suttichaimongkol Yupa Thawornpitak |
2016 | ||||
| 46. | Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy | Piratvisuth, T Komolmit, P Chan, HL Tanwandee, T Sukeepaisarnjaroen, W Pessoa, MG Fassio, E Ono, SK Bessone, F Daruich, J Zeuzem, S Manns, M Uddin, A Dong, Y Trylesinski, A |
2016 | ||||
| 47. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 | ||||
| 48. | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma. | Ann-Lii Cheng Sumitra Thongprasert Ho Yeong Lim Wattana Sukeepaisarnjaroen Tsai-Shen Yang Cheng-Chung Wu Yee Chao Stephen L. Chan Masatoshi Kudo Masafumi Ikeda Yoon-Koo Kang Hongming Pan Kazushi Numata Guohong Han Binaifer Balsara Yong Zhang Ana-Marie Rodriguez Yi Zhang Yongyu Wang Ronnie T. P. Poon |
2016 | ||||
| 49. | The association of S267F variant on NTCP (SLC10A1), a hepatitis B viral surface receptor, and treatment response with pegylated interferon in chronic hepatitis B patients: a multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Tawesak Tanwandee Phunchai Charatcharoenwitthaya Satawat Thongsawat Apinya Leerapun Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Yong Poovorawan Piyawat Komolmit |
2016 | ||||
| 50. | Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study | Phunchai Charatcharoenwitthaya Wattana Sukeepaisarnjaroen Teerha Piratvisuth Satawat Thongsawat Theeranun Sanpajit Soonthorn Chonprasertsuk Woramon Jeamsripong Ekawee Sripariwuth Piyawat Komolmit Tanisa Patcharatrakul Rattana Boonsirichan Chalermrat Bunchorntavakul Supoj Tuntipanichteerakul Tawesak Tanwandee |
2016 | ||||
| 51. | A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma | Sukeepaisarnjaroen, W. | 2017 | ||||
| 52. | Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjects | T. Tanwandee S. Chatsiricharoenkul S. Thongsawat W. Sukeepaisarnjaroen P. Tangkijvanich P. Komolmit A. Avihingsanon T. Piratvisuth P. Sunthi T. Mahasanprasert T. Matkovits M. Conover J. Cobb C. Canizares J. Sullivan-Bolyai |
2017 | ||||
| 53. | Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses | Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Piyawat Komolmit Anchalee Avihingsanon Teerha Piratvisuth |
2017 | ||||
| 54. | Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir | H. Wedemeyer A. J. Hui W. Sukeepaisarnjaroen P. Tangkijvanich W. W. Su G. E. G. Nieto P. Gineste J. Nitcheu S. Crabe S. Stepien M. Cornberg C. Trepo |
2017 | ||||
| 55. | Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients | Sukeepaisarnjaroen, W. Wasitthankasem, R. Poovorawan, Y. |
2017 | ||||
| 56. | A Hospital-Based Study of Intestinal Capillariasis in Thailand: Clinical Features, Potential Clues for Diagnosis, and Epidemiological Characteristics of 85 Patients. | Lakkhana Sadaow Oranuch Sanpool Pewpan M. Intapan Wattana Sukeepaisarnjaroen Thidarat K. Prasongdee Wanchai Maleewong |
2018 | ||||
| 57. | Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study. | Sukeepaisarnjaroen, W. Charatcharoenwitthaya, P. Poovorawan, Y. |
2018 | ||||
| 58. | Contrasting timing of virological relapse after discontinuation of tenofovir or entecavir in Hepatitis B e antigen-negative patients | Höner Zu Siederdissen, C Hui, AJ Sukeepaisarnjaroen, W Tangkijvanich, P Su, WW Nieto, GEG Gineste, P Nitcheu, J Crabé, S Stepien, S Manns, MP Trépo, C Wedemeyer, H Cornberg, M |
2018 | ||||
| 59. | Economic evaluation of palliative biliary drainage in unresectable hilar cholangiocarcinoma | Sangchan, A. Mairiang, P. Mairiang, E. Sukeepaisarnjaroen, W. Chunlertlith, K. Sawadpanich, K. |
2018 | ||||
| 60. | EVALUATION OF BEDSIDE BIOMARKERS APRI AND FIB4 SCORES FOR HEPATIC FIBROSIS ASSESSMENT COMPARED WITH TRANSIENT ELASTOGRAPHY (TE) IN CHRONIC HEPATITIS C PATIENTS | Pimsiri Sripongpun Pisit Tangkijvanich Roongruedee Chaiteerakij Kittiyod Poovorawan Abhasnee Sobhonslidsuk Chalermrat Bunchorntavakul Sakkarin Chirapongsathorn Sith Siramolpiwat Suparat Khemnark Apinya Leerapun Sombat Treeprasertsuk Watcharasak Chotiyaputta Wirichada Pan-Ngum Ngamphol Soonthornworasiri Wattana Sukeepaisarnjaroen |
2018 | ||||
| 61. | Individualized cancer vaccine to elicit tumor debulking immunity in advanced HCC | Michael Har-Noy Wattana Sukeepaisarnjaroen Wirote Lausoontornsiri Aaron Wittenberg Miriam Bloch Tehila Sonnenfeld |
2018 | ||||
| 62. | Personalized vaccine for advanced HCC. | Wirote Lausoontornsiri Michael Har-Noy Jitraporn Wongwiwatcha Miriam Bloch Supaporn Suparak Anucha Ahooja Michael Bishop Wattana Sukeepaisarnjaroen |
2018 | ||||
| 63. | Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma. | Lim, HY Merle, P Weiss, KH Yau, T Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM |
2018 | ||||
| 64. | Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma | Ho Yeong Lim Philippe Merle Karl Heinz Weiss Thomas Yau Paul Ross Vincenzo Mazzaferro Jean-Frederic Blanc Yuk Ting Ma Chia Jui Yen Judit Kocsis Su Pin Choo Wattana Sukeepaisarnjaroen Rene Gerolami Jean-Francois Dufour Edward J. Gane Baek-Yeol Ryoo Markus Peck-Radosavljevic Thong Dao Winnie Yeo Wisut Lamlertthon Satawat Thongsawat Michael Teufel Katrin Roth Diego Reis Barrett H. Childs Heiko Krissel Josep M. Llovet |
2018 | ||||
| 65. | The role of pegylated interferon and ribavirin in chronic hepatitis C genotype 3: A study of real-world practice in Southeast Asia | Sukeepaisarnjaroen, W. | 2018 | ||||
| 66. | Transient elastography for detecting significant liver fibrosis in Thai patients with chronic hepatitis C | Sangaimwibool , Sukeepaisarnjaroen, W. |
2018 | ||||
| 67. | Treatment outcomes and costs of pegylated interferon and ribavirin therapy in chronic hepatitis C virus infection | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2018 | ||||
| 68. | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | Qin, S Chan, SL Sukeepaisarnjaroen, W Han, G Choo, SP Sriuranpong, V Pan, H Yau, T Guo, Y Chen, M Ren, Z Xu, J Yen, CJ Lin, ZZ Manenti, L Gu, Y Sun, Y Tiedt, R Hao, L Song, W Tanwandee, T |
2019 | ||||
| 69. | Diagnostic performance and correlation of hepatitis C virus core antigen compared with hepatitis C virus RNA | Sukeepaisarnjaroen, W. | 2019 | ||||
| 70. | Genetic associations of Vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Tangkijvanich, P Thaimai, P Wasitthankasem, R Poovorawan, Y Komolmit, P |
2019 | ||||
| 71. | Predictive factors for survival time of 273 inoperable hilar cholangiocarcinoma patients: Disease registry analyses | Mairiang, P. Mairiang, E. Sawadpanitch, K. Sangchan, A. Sukeepaisarnjaroen, W. Chunlertrith, K. |
2019 | ||||
| 72. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients | Kookwan Sawadpanich Pisit Soison Kitti Chunlertrith Pisaln Mairiang Wattana Sukeepaisarnjaroen Apichat Sangchan Tanita Suttichaimongkol Chingching Foocharoen |
2019 | ||||
| 73. | PROGNOSTIC FACTORS FOR REMISSION, RELAPSE AND TREATMENT COMPLICATIONS OF TYPE 1 AUTOIMMUNE HEPATITIS IN THAILAND | Nitipat Sandusadee Tanita Suttichaimongkol Wattana Sukeepaisarnjaroen |
2019 | ||||
| 74. | SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND ANTIVIRAL ACTIVITY OF THE CAPSID INHIBITOR (CI) AB-506 IN HEALTHY SUBJECTS (HS) AND CHRONIC HEPATITIS B (CHB) SUBJECTS | Man-Fung Yuen Elina Berliba Wattana Sukeepaisarnjaroen Sang Hoon Ahn Tawesak Tanwandee Young-Suk Lim Yoon Jun Kim Kittiyod Poovorawan Pisit Tangkijvanich Henry Lik Yuen Chan Timothy Eley Joanne Brown Christopher Moore Amy C. H. Lee Jin Kim Emily P. Thi Nagraj Mani Rene Rijnbrand Andrew Cole Michael J. Sofia Gaston R. Picchio Karen Sims Edward J. Gane |
2019 | ||||
| 75. | Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre study | Sukeepaisarnjaroen, W. Charatcharoenwitthaya, P. Poovorawan, Y. |
2019 | ||||
| 76. | Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Treeprasertsuk, S Tanwandee, T Charatcharoenwitthaya, P Thongsawat, S Leerapun, A Piratvisuth, T Boonsirichan, R Bunchorntavakul, C Pattanasirigool, C Pornthisarn, B Tuntipanichteerakul, S Sripariwuth, E Jeamsripong, W Sanpajit, T Poovorawan, Y Komolmit, P |
2019 | ||||
| 77. | An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia | Michael R. Charlton Altaf Alam Akash Shukla Bekhbold Dashtseren Cosmas Rinaldi Adithya Lesmana Davadoorj Duger Diana Alcantara Payawal Do Duy Cuong Ganbolor Jargalsaikhan Ian Homer Yee Cua Jose Decena Sollano Karam Romeo Singh Kaushal Madan Khin Maung Win Khin Pyone Kyi Kyaw Soe Tun Mohd. Salih Mukul Rastogi Neeraj Saraf Pham Thi Thu Thuy Pham Tran Dieu Hien Rino Alvani Gani Rosmawati Mohamed Tawesak Tanwandee Teerha Piratvisuth Wattana Sukeepaisarnjaroen Win Naing Zahid Yasin Hashmi |
2020 | ||||
| 78. | Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. | Edward John Gane Michael R. Charlton Rosmawati Mohamed Jose Decena Sollano Kyaw Soe Tun Thuy Thi Thu Pham Diana Alcantara Payawal Rino Alvani Gani David Handojo Muljono Subrat Kumar Acharya Hui Zhuang Akash Shukla Kaushal Madan Neeraj Saraf Satyendra Tyagi Karam Romeo Singh Ian Homer Yee Cua Ganbolor Jargalsaikhan Davadoorj Duger Wattana Sukeepaisarnjaroen Hery Djagat Purnomo Irsan Hasan Laurentius Adrianto Lesmana Cosmas Rinaldi Adithya Lesmana Khin Pyone Kyi Win Naing Allampura Chandrashekar Ravishankar Sanjay Hadigal |
2020 | ||||
| 79. | Diagnostic Performance of Fibrotest/Actitest for Staging Significant Liver Fibrosis in Thai Chronic Hepatitis C Patients | Tangvoraphonkchai, K. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2020 | ||||
| 80. | Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients | Pimsiri Sripongpun Pisit Tangkijvanich Watcharasak Chotiyaputta Phunchai Charatcharoenwitthaya Roongruedee Chaiteerakij Sombat Treeprasertsuk Chalermrat Bunchorntavakul Abhasnee Sobhonslidsuk Apinya Leerapun Suparat Khemnark Kittiyod Poovorawan Sith Siramolpiwat Sakkarin Chirapongsathorn Wirichada Pan-Ngum Ngamphol Soonthornworasiri Wattana Sukeepaisarnjaroen |
2020 | ||||
| 81. | IDENTIFICATION OF MULTIMARKER PANELS FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA (HCC) THROUGH EXHAUSTIVE SEARCH | Henry Lik Yuen Chan Teerha Piratvisuth Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Juan Ignacio Esteban Mur Marta Bes Bruno Koehler Marcus-Rene Lisy Christine Belz Vinzent Rolny Magdalena Swiatek-De Lange Dave Morgenstern |
2020 | ||||
| 82. | ON-GOING REGISTRY TO UNDERSTAND PATIENT CHARACTERISTICS AND TREATMENT OUTCOMES IN ADULTS WITH CHRONIC HEPATITIS C INFECTION ACROSS ASIA AND AFRICA | Akash Shukla Asad Ali Choudhry Charles Onyekwere Hery Djagat Purnomo Karam Romeo Singh Kyaw Soe Tun Leolin Katsidzira Teerha Piratvisuth Umed Ismoilov Wattana Sukeepaisarnjaroen Zeeshan Ul Haque Sanjay Hadigal Gagan Dua Ravishankar Naidu |
2020 | ||||
| 83. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis | Sandusadee, N Sukeepaisarnjaroen, W Suttichaimongkol, T |
2020 | ||||
| 84. | Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: A multicentre cohort study | Charatcharoenwitthaya, P Wongpaitoon, V Komolmit, P Sukeepaisarnjaroen, W Tangkijvanich, P Piratvisuth, T Sanpajit, T Sutthivana, C Bunchorntavakul, C Sobhonslidsuk, A Chonprasertsuk, S Siripipattanamongkol, C Sethasine, S Tanwandee, T , |
2020 | ||||
| 85. | Tongdee, S Sawunyavisuth, B Sukeepaisarnjaroen, W Boonsawat, W Khamsai, S Sawanyawisuth, K |
2021 | |||||
| 86. | Clinical factors predictive of appropriate treatment in COPD: a community hospital setting | Tongdee, S. Sawunyavisuth, B. Sukeepaisarnjaroen, W. Boonsawat, W. Khamsai, S. Sawanyawisuth, K. |
2021 | ||||
| 87. | Hypertensive crisis in patients with obstructive sleep apnea-induced hypertension. | Sittichai Khamsai Apichart Chootrakool Panita Limpawattana Jarin Chindaprasirt Wattana Sukeepaisarnjaroen Verajit Chotmongkol Songkwan Silaruks Vichai Senthong Yuwares Sittichanbuncha Bundit Sawunyavisuth Kittisak Sawanyawisuth |
2021 | ||||
| 88. | LOW HBsAg LEVELS MAINTAINED FOLLOWING CESSATION OF THE GALNAC-siRNA, AB-729, IN CHRONIC HEPATITIS B SUBJECTS ON NUCLEOS(T)IDE ANALOGUE THERAPY | Man Fung Yuen Elina Berliba Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Apinya Leerapun Jacinta A. Holmes Edward J. Gane Alina Jucov Emily P. Thi Michael J. Sofia Heather Sevinsky Timothy Eley Elina Medvedeva Kevin Gray Deana Antoniello Gaston R. Picchio Karen Sims Simone I. Strasser |
2021 | ||||
| 89. | Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study | Teerha Piratvisuth Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Juan Ignacio Esteban Marta Bes Bruno Koehler Ying He Magdalena Swiatek-de Lange David Morgenstern Henry Lik-Yuen Chan |
2021 | ||||
| 90. | Prevalence and factors correlated with hypertension secondary from obstructive sleep apnea. | Khamsai, S. Limpawattana, P. Sukeepaisarnjaroen, W. Silaruks, S. Senthong, V. |
2021 | ||||
| 91. | Restoration of HBV-specific immune responses with therapeutic vaccine BRII-179 (VBI-2601) in chronic HBV patients in a phase 1b/2a study | Haiyan Ma Tien Huey Lim Apinya Leerapun Martin Weltman Ji-Dong Jia Young-Suk Lim Pisit Tangkijvanich Wattana Sukeepaisarnjaroen Nina Le Bert Yun Ji Dong Li Yao Zhang Robert Hamatake Simone Strasser Chunming Li Huiguo Ding Jung-Hwan Yoon Stace Nigel David Anderson Li Yan Antonio Bertoletti Qing Zhu Man-Fung Yuen |
2021 | ||||
| 92. | Surveillance for hepatitis b virus seroprevalence nearly 30 years after the implementation of a national vaccination program | Tanita Suttichaimongkol Chitchai Rattananukrom Arthit Wongsaensook Kittisak Sawanyawisuth Wattana Sukeepaisarnjaroen |
2021 | ||||
| 93. | THE PHARMACOKINETIC AND SAFETY PROFILES OF RO7445482 siRNA ARE SIMILAR BETWEEN ASIAN AND NON-ASIAN HEALTHY VOLUNTEERS AND CHRONIC HEPATITIS B PATIENTS IN A PHASE 1 STUDY | Edward J. Gane Nelson Guerreiro Simon Buatois Won Kim Jung-Hwan Yoon Tien Huey Lim William Sievert Alexander Thompson Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Christian Schwabe Bob D. Brown Miriam Triyatni Qingyan Bo Hardean Achneck Man-Fung Yuen |
2021 | ||||
| 94. | Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study | Ma, H. Lim, T.H. Leerapun, A. Weltman, M. Jia, J. Lim, Y.s. Tangkijvanich, P. Sukeepaisarnjaroen, W. Ji, Y. Le Bert, N. Li, D. Zhang, Y. Hamatake, R. Tan, N. Li, C. Strasser, S.I. Ding, H. Yoon, J.H. Stace, N.H. Ahmed, T. Anderson, D.E. Yan, L. Bertoletti, A. Zhu, Q. Yuen, M.F. |
2021 | ||||
| 95. | What are the strongest indicators of intracerebral hemorrhage in mild traumatic brain injury? | Teeratakulpisarn, P Angkasith, P Wannakul, T Tanmit, P Prasertcharoensuk, S Thanapaisal, C Wongkonkitsin, N Kitkhuandee, A Sukeepaisarnjaroen, W Phuttharak, W Sawanyawisuth, K |
2021 | ||||
| 96. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population | Chirapongsathorn, S Teerasarntipan, T Tipchaichatta, K Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 | ||||
| 97. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease | Tangvoraphonkchai, K Suttichaimongkol, T Kularbkaew, C Sangaimwibool, P Sukeepaisarnjaroen, W |
2022 | ||||
| 98. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort. | Suttichaimongkol, T. Rattananukrom, C. Wongsaensook, A. Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2022 | ||||
| 99. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. | Kelley, R.K. Rimassa, L. Cheng, A.-L. Kaseb, A. Qin, S. Zhu, A.X. Chan, S.L. Melkadze, T. Sukeepaisarnjaroen, W. Breder, V. Verset, G. Gane, E. Borbath, I. Rangel, J.D.G. Ryoo, B.-Y. Makharadze, T. Merle, P. Benzaghou, F. Banerjee, K. Hazra, S. Fawcett, J. Yau, T. |
2022 | ||||
| 100. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2022 | ||||
| 101. | Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. | Malik, J. Klammer, M. Rolny, V. Chan, H.L.Y. Piratvisuth, T. Tanwandee, T. Thongsawat, S. Sukeepaisarnjaroen, W. Esteban, J.I. Bes, M. |
2022 | ||||
| 102. | Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand. | Chayanupatkul, M. Sukeepaisarnjaroen, W. |
2022 | ||||
| 103. | Evaluation of total immunoglobulin G and subclass antibodies in an enzyme-linked immunosorbent assay for serodiagnosis of human amebic liver abscess. | Janwan, P. Sadaow, L. Rodpai, R. Yamasaki, H. Luvira, V. Sukeepaisarnjaroen, W. Kitkhuandee, A. Paonariang, K. Sanpool, O. Boonroumkaew, P. Thanchomnang, T. Intapan, P.M. Maleewong, W. |
2022 | ||||
| 104. | High Prevalence of Intestinal Capillariasis in Chronic Diarrhea Patients in Thailand: Serological Screening Using a Rapid Lateral-Flow Immunochromatographic Assay. | Prasongdee, TK Seesui, K Sadee, P Sadaow, L Sukeepaisarnjaroen, W Kraiklang, R Sanpool, O Maleewong, W Intapan, PM |
2022 | ||||
| 105. | Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study | Piratvisuth, T Tanwandee, T Thongsawat, S Sukeepaisarnjaroen, W Esteban, JI Bes, M Köhler, B He, Y Swiatek-de Lange, M Morgenstern, D Chan, HL |
2022 | ||||
| 106. | Oxygen saturation is associated with recurrent primary spontaneous pneumothorax treated by intercostal chest drainage | Namwaing, P Chaisuksant, S Sawadpanich, R Anukunananchai, T Timinkul, A Sakaew, W Sawunyavisuth, B Sukeepaisarnjaroen, W Khamsai, S Sawanyawisuth, K |
2022 | ||||
| 107. | Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis | Rodpai, R Luvira, V Sadaow, L Sukeepaisarnjaroen, W Kitkhuandee, A Paonariang, K Sanpool, O Ittiprasert, W Mann, VH Intapan, PM Brindley, PJ Maleewong, W |
2022 | ||||
| 108. | Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B | Yuen, MF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, YS Kim, YJ Poovorawan, K Tangkijvanich, P Schwabe, C Eley, T Brown, J Lee, ACH Thi, EP Paratala, B Mani, N Sofia, MJ Picchio, G Sims, KD Gane, EJ |
2022 | ||||
| 109. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study | Teerasarntipan, T Thanapirom, K Chirapongsathorn, S Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 | ||||
| 110. | An association between calcium channel blocker and breast cancer in patients with hypertension: A case-control study | Supannaroj, R. Khamsai, S. Chindaprasirt, J. Sukeepaisarnjaroen, W. Limpawattana, P. Sawanyawisuth, K. |
2023 | ||||
| 111. | Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry | Chirapongsathorn, S Sukeepaisarnjaroen, W Treeprasertsuk, S Chaiteerakij, R Surawongsin, P Hongthanakorn, C Siramolpiwat, S Chamroonkul, N Bunchorntavakul, C Chotiyaputta, W Poovorawan, K Boonsirichan, R Lawpoolsri, S Sutivana, C Sobhonslidsuk, A |
2023 | ||||
| 112. | Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. | Kohansal-Nodehi, M. Swiatek-de Lange, M. Kroeniger, K. Rolny, V. Tabarés, G. Piratvisuth, T. Tanwandee, T. Thongsawat, S. Sukeepaisarnjaroen, W. Esteban, J.I. Bes, M. |
2023 | ||||
| 113. | First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection | Gane, EJ Kim, W Lim, TH Tangkijvanich, P Yoon, JH Sievert, W Sukeepaisarnjaroen, W Thompson, AJ Pavlovic, V Surujbally, B Wat, C Brown, BD Achneck, HE Yuen, MF |
2023 | ||||
| 114. | Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Do, WL Wang, L Forgues, M Liu, J Rabibhadana, S Pupacdi, B Zhao, Y Gholian, H Bhudhisawasdi, V Pairojkul, C Sukeepaisarnjaroen, W Pugkhem, A Luvira, V Lertprasertsuke, N Chotirosniramit, A Auewarakul, CU Ungtrakul, T Sricharunrat, T Sangrajrang, S Phornphutkul, K Budhu, A Harris, CC Mahidol, C Ruchirawat, M Wang, XW |
2023 | ||||
| 115. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. | Suttichaimongkol, T. Mitpracha, M. Tangvoraphonkchai, K. Sadee, P. Sawanyawisuth, K. Sukeepaisarnjaroen, W. |
2023 | ||||
| 116. | Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer). | Abou-Alfa, GK Lau, G Kudo, M Chan, SL Kelley, RK Furuse, J Sukeepaisarnjaroen, W Kang, YK Dao, TV De Toni, EN Rimassa, L Breder, V Vasilyev, A Heurgué, A Tam, VC Mody, K Thungappa, SC Ostapenko, Y Yau, T Azevedo, S Varela, M Cheng, AL Qin, S Galle, PR Ali, S Gupta, C Makowsky, M Kurland, JF Negro, A Sangro, B |
2023 | ||||
| 117. | A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis. | Köhler, B Bes, M Chan, HL Esteban, JI Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Thongsawat, S Mang, A Morgenstern, D Swiatek-de Lange, M Dayyani, F |
2024 | ||||
| 118. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study. | Yau, T Kaseb, A Cheng, AL Qin, S Zhu, AX Chan, SL Melkadze, T Sukeepaisarnjaroen, W Breder, V Verset, G Gane, E Borbath, I Rangel, JDG Ryoo, BY Makharadze, T Merle, P Benzaghou, F Milwee, S Wang, Z Curran, D Kelley, RK Rimassa, L |
2024 | ||||
| 119. | Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand. | Sriphoosanaphan, S. Pantumongkol, W. Kulpeng, W. Charonpongsuntorn, C. Tanwandee, T. Sukeepaisarnjaroen, W. Sobhonslidsuk, A. Tangkijvanich, P. |
2024 | ||||
| 120. | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. | Sangro, B. Chan, S.L. Kelley, R.K. Lau, G. Kudo, M. Sukeepaisarnjaroen, W. Yarchoan, M. De Toni, E.N. Furuse, J. Kang, Y.K. Galle, P.R. |
2024 | ||||
| 121. | Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment | Mohamed, R. Wang, W. Tanwandee, T. Hasan, I. Pham, C.P. Lim, Y.S. Lu, S.N. Munisamy, M. Tran, T.T.H. Ratnawati, E. Sukeepaisarnjaroen, W. Karababa, M. Tan, C.K. |
2024 | ||||
| 122. | Pooled prevalences of obstructive sleep apnea and heart failure: a systematic review and meta-analysis | Prechaporn, W Hantrakul, P Ngamjarus, C Sukeepaisarnjaroen, W Sawanyawisuth, K Khamsai, S |
2024 | ||||
| 123. | Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. | Toyoda, H Kanneganti, M Melendez-Torres, J Parikh, ND Jalal, PK Piñero, F Mendizabal, M Ridruejo, E Cheinquer, H Casadei-Gardini, A Weinmann, A Peck-Radosavljevic, M Dufour, JF Radu, P Shiha, G Soliman, R Sarin, SK Kumar, M Wang, JH Tangkijvanich, P Sukeepaisarnjaroen, W Atsukawa, M Uojima, H Nozaki, A Nakamuta, M Takaguchi, K Hiraoka, A Abe, H Matsuura, K Watanabe, T Shimada, N Tsuji, K Ishikawa, T Mikami, S Itobayashi, E Singal, AG Johnson, PJ |
2024 | ||||
| 124. | Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma | Toyoda, H. Kanneganti, M. Melendez-Torres, J. Parikh, N.D. Jalal, P.K. Piñero, F. Mendizabal, M. Ridruejo, E. Cheinquer, H. Casadei-Gardini, A. Weinmann, A. Peck-Radosavljevic, M. Dufour, J.F. Radu, P. Shiha, G. Soliman, R. Sarin, S.K. Kumar, M. Wang, J.H. Tangkijvanich, P. Sukeepaisarnjaroen, W. Atsukawa, M. Uojima, H. Nozaki, A. Nakamuta, M. Takaguchi, K. Hiraoka, A. Abe, H. Matsuura, K. Watanabe, T. Shimada, N. Tsuji, K. Ishikawa, T. Mikami, S. Itobayashi, E. Singal, A.G. Johnson, P.J. |
2024 | ||||
| 125. | The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand. | Pupacdi, B Loffredo, CA Budhu, A Rabibhadana, S Bhudhisawasdi, V Pairojkul, C Sukeepaisarnjaroen, W Pugkhem, A Luvira, V Lertprasertsuke, N Chotirosniramit, A Auewarakul, CU Ungtrakul, T Sricharunrat, T Sangrajrang, S Phornphutkul, K Albert, PS Kim, S Harris, CC Mahidol, C Wang, XW Ruchirawat, M , |
2024 | ||||
| 126. | Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA Phase 3 randomized clinical trial | Lau, G. Sangro, B. Cheng, A.L. Kudo, M. Kelley, R.K. Tak, W.Y. Gasbarrini, A. Reig, M. Lim, H.Y. Tougeron, D. De Toni, E.N. Tam, V.C. Mody, K. Gong, J. Crysler, O.V. Sukeepaisarnjaroen, W. Lipatov, O. Morimoto, M. Archambeaud, I. Burgio, V. Phuong, L.T.T. Chao, Y. Peron, J.M. |
2025 | ||||
| 127. | Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma | Sadaow, L Rodpai, R Smout, MJ Nakajima, R Boonroumkaew, P Sotillo, J Tedla, BA Luvira, V Kitkhuandee, A Paonariang, K Sukeepaisarnjaroen, W Yamasaki, H Suttiprapa, S Laha, T Sripa, B de Assis, R Jain, A Ittiprasert, W Mann, VH Wong, Y Felgner, PL Maleewong, W Brindley, PJ Loukas, A Intapan, PM |
2025 | ||||
| 128. | Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. | Lau, G Abou-Alfa, GK Cheng, AL Sukeepaisarnjaroen, W Van Dao, T Kang, YK Thungappa, SC Kudo, M Sangro, B Kelley, RK Furuse, J Park, JW Sunpaweravong, P Fasolo, A Yau, T Kawaoka, T Azevedo, S Reig, M Assenat, E Yarchoan, M He, AR Makowsky, M Gupta, C Negro, A Chan, SL |
2025 | Count | 75 | 75 | 60 | 1 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Intestinal capillariasis: A cause of chronic diarrhea and hypoalbuminemia | Chunlertrith, K. Mairiang, P. Sukeepaisarnjaroen, W. |
1992 |
Southeast Asian Journal of Tropical Medicine and Public Health 3 (23), pp. 433-436 |
||||||||
| 2. | The study of discriminant values of dyspeptic symptoms for identifying the etiology of dyspepsia. | Chunlertrith, K. Sukeepaisarnjaroen, W. Mairiang, E. Laopaiboon, V. Pairojkul, C. Bhudhisawasdi, V. |
1992 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 6 (75), pp. 341-349 |
||||||||
| 3. | Comparison of adult somatic and excretory-secretory antigens in enzyme-linked immunosorbent assay for serodiagnosis of human infection with Fasciola gigantica | Maleewong, W. Intapan, P.M.A. Wongkham, C. Tomanakan, K. Daenseekaew, W. Sukeepaisarnjaroen, W. |
1996 |
Southeast Asian Journal of Tropical Medicine and Public Health 3 (27), pp. 566-569 |
||||||||
| 4. | Clinico-epidemiology of hepatitis B viral infection in Northeastern Thailand | Chunlertrith, K. Sukeepaisarnjaroen, W. Mairiang, P. Urwijitaroon, Y. Takase, K. Yamauchi, T. Yoshimura, H. Tameda, Y. |
2000 |
Southeast Asian Journal of Tropical Medicine and Public Health 1 (31), pp. 37-40 |
||||||||
| 5. | Clinico-epidemiology of hepatitis C viral infection in Northeastern Thailand | Chunlertrith, K. Sukeepaisarnjaroen, W. Mairiang, P. Urwijitaroon, Y. Takase, K. Yamauchi, T. Yoshimura, H. Tameda, Y. |
2000 |
Southeast Asian Journal of Tropical Medicine and Public Health 2 (31), pp. 273-276 |
||||||||
| 6. | Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis | Intapan, P.M.A. Maleewong, W. Sukeepaisarnjaroen, W. Morakote, N. |
2006 |
Parasitology Research 3 (98), pp. 227-231 |
||||||||
| 7. | The endoscopic-pathologic findings in intestinal capillariais: A case report | Sangchan, A. Wongsaensook, A. Kularbkaew, C. Sawanyawisuth, K. Sukeepaisarnjaroen, W. Mairiang, P. |
2007 |
Journal of the Medical Association of Thailand 1 (90), pp. 175-178 |
||||||||
| 8. | An enzyme-linked immunosorbent assay as screening tool for human intestinal capillariasis | Intapan, P.M.A. Maleewong, W. Sukeepaisarnjaroen, W. Morakote, N. |
2010 |
Southeast Asian Journal of Tropical Medicine and Public Health 2 (41), pp. 298-305 |
||||||||
| 9. | Images in clinical tropical medicine: Biliary ascariasis after worm removal from the duodenum and single-dose albendazole treatment | Wongsaensook, A. Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2010 |
American Journal of Tropical Medicine and Hygiene 1 (83), pp. 7-8 |
||||||||
| 10. | Hospitalized incidence and outcomes of upper gastrointestinal bleeding in Thailand. | Sangchan, A. Sawadpanitch, K. Mairiang, P. Chunlertrith, K. Sukeepaisarnjaroen, W. Sutra, S. Thavornpitak, Y. |
2012 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet (95 Suppl 7), pp. |
||||||||
| 11. | Significant clinical risks and the benefits of liver biopsies in Srinagarind Hospital, Khon Kaen University, Thailand: Lessons learned from the past to the present | Wongsaensook, A. Sukeepaisarnjaroen, W. Sukeepaisarnjaroen, W. Kularbkaew, C. |
2012 |
Interventional Medicine and Applied Science 2 (4), pp. 92-97 |
||||||||
| 12. | 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B | Sukeepaisarnjaroen, W. Chan, H.L. Ono, S. |
2013 |
PLoS ONE 2 (8), pp. |
||||||||
| 13. | Sonographic findings of hepatocellular carcinoma detected in ultrasound surveillance of cirrhotic patients | Chamadol, N. Somsap, K. Laopaiboon, V. Sukeepaisarnjaroen, W. |
2013 |
Journal of the Medical Association of Thailand 7 (96), pp. 829-838 |
||||||||
| 14. | Differential diagnosis of ulcers throughout the colon | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2014 |
Revista da Sociedade Brasileira de Medicina Tropical 3 (47), pp. 401 |
||||||||
| 15. | Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2014 |
Tropical gastroenterology : official journal of the Digestive Diseases Foundation 4 (35), pp. 260-261 |
||||||||
| 16. | GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis | Chunlertrith, K. Noiprasit, A. Foocharoen, C. Mairiang, P. Sukeepaisarnjaroen, W. Sangchan, A. Sawadpanitch, K. |
2014 |
Clinical and experimental rheumatology 6 (32), pp. |
||||||||
| 17. | Association between CXCL10 and DPP4 gene polymorphisms and a complementary role for unfavorable IL28B genotype in prediction of treatment response in Thai patients with chronic hepatitis C virus infection | Sukeepaisarnjaroen, W. Wasitthankasem, R. Poovorawan, Y. |
2015 |
PLoS ONE 9 (10), pp. |
||||||||
| 18. | Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers | Sukeepaisarnjaroen, W. Tan, S. Dan, Y. |
2015 |
World Journal of Gastroenterology 28 (21), pp. 8660-8669 |
||||||||
| 19. | Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy | Chan, H.L. Sukeepaisarnjaroen, W. Ono, S. |
2016 |
Drugs in Context (5), pp. |
||||||||
| 20. | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma | Sukeepaisarnjaroen, W. | 2016 |
Hepatology (), pp. |
||||||||
| 21. | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma | Sukeepaisarnjaroen, W. | 2016 |
Hepatology 3 (64), pp. 774-784 |
||||||||
| 22. | Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study | Charatcharoenwitthaya, P. Sukeepaisarnjaroen, W. |
2016 |
Journal of Gastroenterology and Hepatology (Australia) 11 (31), pp. 1874-1881 |
||||||||
| 23. | A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma | Sukeepaisarnjaroen, W. | 2017 |
Clinical Cancer Research 10 (23), pp. 2405-2413 |
||||||||
| 24. | Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients | Sukeepaisarnjaroen, W. Wasitthankasem, R. Poovorawan, Y. |
2017 |
BMC Gastroenterology 1 (17), pp. |
||||||||
| 25. | A Hospital-Based study of intestinal capillariasis in Thailand: Clinical features, potential clues for diagnosis, and epidemiological characteristics of 85 patients | Sadaow, L. Sanpool, O. Intapan, P.M. Sukeepaisarnjaroen, W. Prasongdee, T.K. Maleewong, W. |
2018 |
American Journal of Tropical Medicine and Hygiene 1 (98), pp. 27-31 |
||||||||
| 26. | Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre study | Sukeepaisarnjaroen, W. Charatcharoenwitthaya, P. Poovorawan, Y. |
2018 |
Antiviral Therapy 1 (23), pp. 67-75 |
||||||||
| 27. | Contrasting timing of virological relapse after discontinuation of tenofovir or entecavir in Hepatitis B e antigen-negative patients | Sukeepaisarnjaroen, W. | 2018 |
Journal of Infectious Diseases 9 (218), pp. 1480-1484 |
||||||||
| 28. | Economic evaluation of palliative biliary drainage in unresectable hilar cholangiocarcinoma | Sangchan, A. Mairiang, P. Mairiang, E. Sukeepaisarnjaroen, W. Chunlertlith, K. Sawadpanich, K. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S44-S52 |
||||||||
| 29. | Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma | Choo, S. Sukeepaisarnjaroen, W. |
2018 |
Clinical Cancer Research 19 (24), pp. 4650-4661 |
||||||||
| 30. | The role of pegylated interferon and ribavirin in chronic hepatitis C genotype 3: A study of real-world practice in Southeast Asia | Sukeepaisarnjaroen, W. | 2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S167-S172 |
||||||||
| 31. | Transient elastography for detecting significant liver fibrosis in Thai patients with chronic hepatitis C | Sangaimwibool , Sukeepaisarnjaroen, W. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S66-S71 |
||||||||
| 32. | Treatment outcomes and costs of pegylated interferon and ribavirin therapy in chronic hepatitis C virus infection | Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2018 |
Journal of the Medical Association of Thailand 4 (101), pp. S80-S86 |
||||||||
| 33. | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | Sukeepaisarnjaroen, W. Choo, S. |
2019 |
Therapeutic Advances in Medical Oncology (11), pp. |
||||||||
| 34. | Diagnostic performance and correlation of hepatitis C virus core antigen compared with hepatitis C virus RNA | Sukeepaisarnjaroen, W. | 2019 |
Journal of the Medical Association of Thailand 12 (102), pp. 75-80 |
||||||||
| 35. | Genetic associations of Vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C | Sukeepaisarnjaroen, W. Wasitthankasem, R. Poovorawan, Y. |
2019 |
PeerJ 9 (2019), pp. |
||||||||
| 36. | Predictive factors for survival time of 273 inoperable hilar cholangiocarcinoma patients: Disease registry analyses | Mairiang, P. Mairiang, E. Sawadpanitch, K. Sangchan, A. Sukeepaisarnjaroen, W. Chunlertrith, K. |
2019 |
Journal of the Medical Association of Thailand 12 (102), pp. 43-49 |
||||||||
| 37. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients | Sawadpanich, K. Chunlertrith, K. Mairiang, P. Sukeepaisarnjaroen, W. Sangchan, A. Foocharoen, C. |
2019 |
International Journal of Rheumatic Diseases 4 (22), pp. 695-699 |
||||||||
| 38. | Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre study | Sukeepaisarnjaroen, W. Charatcharoenwitthaya, P. Poovorawan, Y. |
2019 |
Asian Pacific Journal of Cancer Prevention 4 (20), pp. 1257-1264 |
||||||||
| 39. | An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia | Sukeepaisarnjaroen, W. | 2020 |
Journal of Gastroenterology 9 (55), pp. 811-823 |
||||||||
| 40. | Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings | Sukeepaisarnjaroen, W. | 2020 |
Journal of Viral Hepatitis 5 (27), pp. 466-475 |
||||||||
| 41. | Diagnostic Performance of Fibrotest/Actitest for Staging Significant Liver Fibrosis in Thai Chronic Hepatitis C Patients | Tangvoraphonkchai, K. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2020 |
Journal of the Medical Association of Thailand 12 (103), pp. |
||||||||
| 42. | Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients | Charatcharoenwitthaya, P. Chaiteerakij, R. Poovorawan, K. Sukeepaisarnjaroen, W. |
2020 |
JGH Open 1 (4), pp. 69-74 |
||||||||
| 43. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis | Sukeepaisarnjaroen, W. | 2020 |
Heliyon 4 (6), pp. |
||||||||
| 44. | Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: A multicentre cohort study | Charatcharoenwitthaya, P. Sukeepaisarnjaroen, W. |
2020 |
BMC Gastroenterology 1 (20), pp. |
||||||||
| 45. | Clinical factors predictive of appropriate treatment in COPD: a community hospital setting | Tongdee, S. Sawunyavisuth, B. Sukeepaisarnjaroen, W. Boonsawat, W. Khamsai, S. Sawanyawisuth, K. |
2021 |
Drug Target Insights 1 (15), pp. 21-25 |
||||||||
| 46. | Hypertensive crisis in patients with obstructive sleep apnea-induced hypertension | Khamsai, S. Limpawattana, P. Chindaprasirt, J. Sukeepaisarnjaroen, W. Chotmongkol, V. Silaruks, S. Senthong, V. Sittichanbuncha, Y. |
2021 |
BMC Cardiovascular Disorders 1 (21), pp. |
||||||||
| 47. | Prevalence and factors correlated with hypertension secondary from obstructive sleep apnea | Khamsai, S. Limpawattana, P. Sukeepaisarnjaroen, W. Silaruks, S. Senthong, V. |
2021 |
Multidisciplinary Respiratory Medicine (16), pp. |
||||||||
| 48. | Surveillance for hepatitis b virus seroprevalence nearly 30 years after the implementation of a national vaccination program | Wongsaensook, A. Sukeepaisarnjaroen, W. |
2021 |
GERMS 3 (11), pp. 403-407 |
||||||||
| 49. | Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study | Ma, H. Lim, T.H. Leerapun, A. Weltman, M. Jia, J. Lim, Y.s. Tangkijvanich, P. Sukeepaisarnjaroen, W. Ji, Y. Le Bert, N. Li, D. Zhang, Y. Hamatake, R. Tan, N. Li, C. Strasser, S.I. Ding, H. Yoon, J.H. Stace, N.H. Ahmed, T. Anderson, D.E. Yan, L. Bertoletti, A. Zhu, Q. Yuen, M.F. |
2021 |
JHEP Reports 6 (3), pp. |
||||||||
| 50. | What are the strongest indicators of intracerebral hemorrhage in mild traumatic brain injury? | Teeratakulpisarn, P. Tanmit, P. Prasertcharoensuk, S. Thanapaisal, C. Wongkonkitsin, N. Kitkhuandee, A. Sukeepaisarnjaroen, W. Phuttharak, W. |
2021 |
Trauma Surgery and Acute Care Open 1 (6), pp. |
||||||||
| 51. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population | Sukeepaisarnjaroen, W. | 2022 |
JGH Open 3 (6), pp. 205-212 |
||||||||
| 52. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease | Tangvoraphonkchai, K. Kularbkaew, C. Sangaimwibool, P. Sukeepaisarnjaroen, W. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 53. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort | Suttichaimongkol, T. Rattananukrom, C. Wongsaensook, A. Sukeepaisarnjaroen, W. Sawanyawisuth, K. |
2022 |
Journal of Preventive Medicine and Hygiene 2 (63), pp. E288-E291 |
||||||||
| 54. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial | Kelley, R.K. Rimassa, L. Cheng, A.-L. Kaseb, A. Qin, S. Zhu, A.X. Chan, S.L. Melkadze, T. Sukeepaisarnjaroen, W. Breder, V. Verset, G. Gane, E. Borbath, I. Rangel, J.D.G. Ryoo, B.-Y. Makharadze, T. Merle, P. Benzaghou, F. Banerjee, K. Hazra, S. Fawcett, J. Yau, T. |
2022 |
The Lancet Oncology 8 (23), pp. 995-1008 |
||||||||
| 55. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter | Tangvoraphonkchai, K. Sadee, P. Sukeepaisarnjaroen, W. |
2022 |
Future Science OA 4 (8), pp. |
||||||||
| 56. | Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma | Malik, J. Klammer, M. Rolny, V. Chan, H.L.Y. Piratvisuth, T. Tanwandee, T. Thongsawat, S. Sukeepaisarnjaroen, W. Esteban, J.I. Bes, M. |
2022 |
World Journal of Gastroenterology 29 (28), pp. 3917-3933 |
||||||||
| 57. | Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand | Chayanupatkul, M. Sukeepaisarnjaroen, W. |
2022 |
Applied Health Economics and Health Policy 4 (20), pp. 587-596 |
||||||||
| 58. | Evaluation of total immunoglobulin G and subclass antibodies in an enzymelinked immunosorbent assay for serodiagnosis of human amebic liver abscess | Janwan, P. Sadaow, L. Rodpai, R. Yamasaki, H. Luvira, V. Sukeepaisarnjaroen, W. Kitkhuandee, A. Paonariang, K. Sanpool, O. Boonroumkaew, P. Thanchomnang, T. Intapan, P.M. Maleewong, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 59. | Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study | Sukeepaisarnjaroen, W. Chan, H.L. |
2022 |
Hepatology Communications 4 (6), pp. 679-691 |
||||||||
| 60. | Oxygen saturation is associated with recurrent primary spontaneous pneumothorax treated by intercostal chest drainage | Chaisuksant, S. Timinkul, A. Sakaew, W. Sukeepaisarnjaroen, W. Khamsai, S. |
2022 |
Asian Journal of Surgery 1 (45), pp. 431-434 |
||||||||
| 61. | Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis | Sadaow, L. Sukeepaisarnjaroen, W. Kitkhuandee, A. Paonariang, K. Sanpool, O. Intapan, P.M. Maleewong, W. |
2022 |
International Journal of Infectious Diseases (116), pp. 80-84 |
||||||||
| 62. | Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B | Yuen, M.F. Berliba, E. Sukeepaisarnjaroen, W. Ahn, S.H. Tanwandee, T. Lim, Y.S. Kim, Y.J. Poovorawan, K. Tangkijvanich, P. Schwabe, C. Eley, T. Brown, J. Lee, A.C.H. Thi, E.P. Paratala, B. Mani, N. Sofia, M.J. Picchio, G. Sims, K.D. Gane, E.J. |
2022 |
Hepatology Communications 12 (6), pp. 3457-3472 |
||||||||
| 63. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study | Teerasarntipan, T. Thanapirom, K. Chirapongsathorn, S. Suttichaimongkol, T. Chamroonkul, N. Bunchorntavakul, C. Siramolpiwat, S. Chainuvati, S. Sobhonslidsuk, A. Leerapun, A. Piratvisuth, T. Sukeepaisarnjaroen, W. Tanwandee, T. Treeprasertsuk, S. |
2022 |
PLoS ONE 11 November (17), pp. |
||||||||
| 64. | An association between calcium channel blocker and breast cancer in patients with hypertension: A case-control study | Supannaroj, R. Khamsai, S. Chindaprasirt, J. Sukeepaisarnjaroen, W. Limpawattana, P. Sawanyawisuth, K. |
2023 |
Medicine in Drug Discovery (20), pp. |
||||||||
| 65. | Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry | Chirapongsathorn, S. Sukeepaisarnjaroen, W. Treeprasertsuk, S. Chaiteerakij, R. Surawongsin, P. Hongthanakorn, C. Siramolpiwat, S. Chamroonkul, N. Bunchorntavakul, C. Chotiyaputta, W. Poovorawan, K. Boonsirichan, R. Lawpoolsri, S. Sutivana, C. Sobhonslidsuk, A. |
2023 |
Journal of Clinical and Translational Hepatology 1 (11), pp. 88-96 |
||||||||
| 66. | Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma | Kohansal-Nodehi, M. Swiatek-de Lange, M. Kroeniger, K. Rolny, V. Tabarés, G. Piratvisuth, T. Tanwandee, T. Thongsawat, S. Sukeepaisarnjaroen, W. Esteban, J.I. Bes, M. |
2023 |
Frontiers in Oncology (13), pp. |
||||||||
| 67. | First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection | Gane, E.J. Kim, W. Lim, T.H. Tangkijvanich, P. Yoon, J.H. Sievert, W. Sukeepaisarnjaroen, W. Thompson, A.J. Pavlovic, V. Surujbally, B. Wat, C. Brown, B.D. Achneck, H.E. |
2023 |
Journal of Hepatology 5 (79), pp. 1139-1149 |
||||||||
| 68. | Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Do, W.L. Wang, L. Forgues, M. Liu, J. Rabibhadana, S. Pupacdi, B. Zhao, Y. Gholian, H. Bhudhisawasdi, V. Pairojkul, C. Sukeepaisarnjaroen, W. Pugkhem, A. Luvira, V. Lertprasertsuke, N. Chotirosniramit, A. Auewarakul, C.U. Ungtrakul, T. Sricharunrat, T. Sangrajrang, S. Phornphutkul, K. |
2023 |
Cell Reports Medicine 12 (4), pp. |
||||||||
| 69. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients | Suttichaimongkol, T. Mitpracha, M. Tangvoraphonkchai, K. Sadee, P. Sawanyawisuth, K. Sukeepaisarnjaroen, W. |
2023 |
Journal of Circulating Biomarkers (12), pp. 12-16 |
||||||||
| 70. | Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand | Sriphoosanaphan, S. Pantumongkol, W. Kulpeng, W. Charonpongsuntorn, C. Tanwandee, T. Sukeepaisarnjaroen, W. Sobhonslidsuk, A. Tangkijvanich, P. |
2024 |
PLoS ONE 3 March (19), pp. |
||||||||
| 71. | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma | Sangro, B. Chan, S.L. Kelley, R.K. Lau, G. Kudo, M. Sukeepaisarnjaroen, W. Yarchoan, M. De Toni, E.N. Furuse, J. Kang, Y.K. Galle, P.R. |
2024 |
Annals of Oncology 5 (35), pp. 448-457 |
||||||||
| 72. | Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment | Mohamed, R. Wang, W. Tanwandee, T. Hasan, I. Pham, C.P. Lim, Y.S. Lu, S.N. Munisamy, M. Tran, T.T.H. Ratnawati, E. Sukeepaisarnjaroen, W. Karababa, M. Tan, C.K. |
2024 |
Journal of Gastrointestinal Cancer 3 (55), pp. 1333-1344 |
||||||||
| 73. | Pooled prevalences of obstructive sleep apnea and heart failure: a systematic review and meta-analysis | Prechaporn, W. Hantrakul, P. Ngamjarus, C. Sukeepaisarnjaroen, W. Sawanyawisuth, K. Khamsai, S. |
2024 |
Heart Failure Reviews 4 (29), pp. 811-826 |
||||||||
| 74. | Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma | Toyoda, H. Kanneganti, M. Melendez-Torres, J. Parikh, N.D. Jalal, P.K. Piñero, F. Mendizabal, M. Ridruejo, E. Cheinquer, H. Casadei-Gardini, A. Weinmann, A. Peck-Radosavljevic, M. Dufour, J.F. Radu, P. Shiha, G. Soliman, R. Sarin, S.K. Kumar, M. Wang, J.H. Tangkijvanich, P. Sukeepaisarnjaroen, W. Atsukawa, M. Uojima, H. Nozaki, A. Nakamuta, M. Takaguchi, K. Hiraoka, A. Abe, H. Matsuura, K. Watanabe, T. Shimada, N. Tsuji, K. Ishikawa, T. Mikami, S. Itobayashi, E. Singal, A.G. Johnson, P.J. |
2024 |
Clinical Gastroenterology and Hepatology 1 (22), pp. 72-80.e4 |
||||||||
| 75. | Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA Phase 3 randomized clinical trial | Lau, G. Sangro, B. Cheng, A.L. Kudo, M. Kelley, R.K. Tak, W.Y. Gasbarrini, A. Reig, M. Lim, H.Y. Tougeron, D. De Toni, E.N. Tam, V.C. Mody, K. Gong, J. Crysler, O.V. Sukeepaisarnjaroen, W. Lipatov, O. Morimoto, M. Archambeaud, I. Burgio, V. Phuong, L.T.T. Chao, Y. Peron, J.M. |
2025 |
Hepatology (), pp. |
||||||||
| 76. | Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma | Sadaow, L. Rodpai, R. Smout, M.J. Nakajima, R. Boonroumkaew, P. Sotillo, J. Tedla, B.A. Luvira, V. Kitkhuandee, A. Paonariang, K. Sukeepaisarnjaroen, W. Yamasaki, H. Suttiprapa, S. Laha, T. Sripa, B. de Assis, R. Jain, A. Ittiprasert, W. Mann, V.H. Wong, Y. Felgner, P.L. Maleewong, W. Brindley, P.J. Loukas, A. Intapan, P.M. |
2025 |
Nature Communications 1 (16), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | The study of discriminant values of dyspeptic symptoms for identifying the etiology of dyspepsia. | Chunlertrith, K Sukeepaisarnjaroen, W Mairiang, E Laopaiboon, V Pairojkul, C Bhudhisawasdi, V |
1992 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 6 (75), pp. 341-9 |
|
| 2. | Intestinal capillariasis: a cause of chronic diarrhea and hypoalbuminemia. | Chunlertrith, K Mairiang, P Sukeepaisarnjaroen, W |
1992 |
The Southeast Asian journal of tropical medicine and public health 3 (23), pp. 433-6 |
|
| 3. | Burkholder meningitis. | Chotmongkol, V Sukeepaisarncharoen, W |
1996 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 4 (79), pp. 263-6 |
|
| 4. | Comparison of adult somatic and excretory-secretory antigens in enzyme-linked immunosorbent assay for serodiagnosis of human infection with Fasciola gigantica. | Maleewong, W Intapan, PM Wongkham, C Tomanakan, K Daenseekaew, W Sukeepaisarnjaroen, W |
1996 |
The Southeast Asian journal of tropical medicine and public health 3 (27), pp. 566-9 |
|
| 5. | Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. | Chotmongkol, V Sukeepaisarncharoen, W |
1997 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 12 (80), pp. 767-70 |
|
| 6. | Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. | Chotmongkol, V Sukeepaisarncharoen, W Thavornpitak, Y |
1997 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 7 (80), pp. 416-25 |
|
| 7. | Clinico-epidemiology of hepatitis C viral infection in northeastern Thailand. | Chunlertrith, K Sukeepaisarnjaroen, W Mairiang, P Urwijitaroon, Y Takase, K Yamauchi, T Yoshimura, H Tameda, Y |
2000 |
The Southeast Asian journal of tropical medicine and public health 2 (31), pp. 273-6 |
|
| 8. | Clinico-epidemiology of hepatitis B viral infection in Northeastern Thailand. | Chunlertrith, K Sukeepaisarnjaroen, W Mairiang, P Urwijitaroon, Y Takase, K Yamauchi, T Yoshimura, H Tameda, Y |
2000 |
The Southeast Asian journal of tropical medicine and public health 1 (31), pp. 37-40 |
|
| 9. | A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected thai subjects with CD4-cell counts of >300. | Churdboonchart, V Sakondhavat, C Kulpradist, S Na Ayudthya, BI Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R |
2000 |
Clinical and diagnostic laboratory immunology 5 (7), pp. 728-33 |
|
| 10. | Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand. | Chantratita, W Sukeepaisarncharoen, W Chandeying, V Kulpradist, S Israngkura Na Ayudhtaya, B Rugpao, S Sirawaraporn, W Boonshuyar, C Churdboonchart, V |
2004 |
HIV medicine 5 (5), pp. 317-25 |
|
| 11. | Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis. | Intapan, PM Maleewong, W Sukeepaisarnjaroen, W Morakote, N |
2006 |
Parasitology research 3 (98), pp. 227-31 |
|
| 12. | The endoscopic-pathologic findings in intestinal capillariais: a case report. | Sangchan, A Wongsaensook, A Kularbkaew, C Sawanyawisuth, K Sukeepaisarnjaroen, W Mairiang, P |
2007 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1 (90), pp. 175-8 |
|
| 13. | Biliary ascariasis after worm removal from the duodenum and single-dose albendazole treatment. | Wongsaensook, A Sukeepaisarnjaroen, W Sawanyawisuth, K |
2010 |
The American journal of tropical medicine and hygiene 1 (83), pp. 7-8 |
|
| 14. | Hospitalized incidence and outcomes of upper gastrointestinal bleeding in Thailand. | Sangchan, A Sawadpanitch, K Mairiang, P Chunlertrith, K Sukeepaisarnjaroen, W Sutra, S Thavornpitak, Y |
2012 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet (95), pp. S190-5 |
|
| 15. | 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B. | Piratvisuth, T Komolmit, P Tanwandee, T Sukeepaisarnjaroen, W Chan, HL Pessôa, MG Fassio, E Ono, SK Bessone, F Daruich, J Zeuzem, S Cheinquer, H Pathan, R Dong, Y Trylesinski, A |
2013 |
PloS one 2 (8), pp. e54279 |
|
| 16. | Sonographic findings of hepatocellular carcinoma detected in ultrasound surveillance of cirrhotic patients. | Chamadol, N Somsap, K Laopaiboon, V Sukeepaisarnjaroen, W |
2013 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 7 (96), pp. 829-38 |
|
| 17. | Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Tangkijvanich, P Treeprasertsuk, S Thaimai, P Wasitthankasem, R Poovorawan, Y Komolmit, P |
2015 |
PloS one 9 (10), pp. e0137365 |
|
| 18. | Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers. | Sukeepaisarnjaroen, W Pham, T Tanwandee, T Nazareth, S Galhenage, S Mollison, L Totten, L Wigg, A Altus, R Colman, A Morales, B Mason, S Jones, T Leembruggen, N Fragomelli, V Sendall, C Guan, R Sutedja, D Tan, SS Dan, YY Lee, YM Luman, W Teo, EK Than, YM Piratvisuth, T Lim, SG |
2015 |
World journal of gastroenterology : WJG 28 (21), pp. 8660-9 |
|
| 19. | Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy. | Piratvisuth, T Komolmit, P Chan, HL Tanwandee, T Sukeepaisarnjaroen, W Pessoa, MG Fassio, E Ono, SK Bessone, F Daruich, J Zeuzem, S Manns, M Uddin, A Dong, Y Trylesinski, A |
2016 |
Drugs in context (5), pp. 212294 |
|
| 20. | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma. | Cheng, AL Thongprasert, S Lim, HY Sukeepaisarnjaroen, W Yang, TS Wu, CC Chao, Y Chan, SL Kudo, M Ikeda, M Kang, YK Pan, H Numata, K Han, G Balsara, B Zhang, Y Rodriguez, AM Zhang, Y Wang, Y Poon, RT |
2016 |
Hepatology (Baltimore, Md.) 3 (64), pp. 774-84 |
|
| 21. | Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study. | Charatcharoenwitthaya, P Sukeepaisarnjaroen, W Piratvisuth, T Thongsawat, S Sanpajit, T Chonprasertsuk, S Jeamsripong, W Sripariwuth, E Komolmit, P Patcharatrakul, T Boonsirichan, R Bunchorntavakul, C Tuntipanichteerakul, S Tanwandee, T , |
2016 |
Journal of gastroenterology and hepatology 11 (31), pp. 1874-1881 |
|
| 22. | Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Tangkijvanich, P Treeprasertsuk, S Thaimai, P Wasitthankasem, R Poovorawan, Y Komolmit, P |
2017 |
BMC gastroenterology 1 (17), pp. 54 |
|
| 23. | A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. | Yau, TCC Lencioni, R Sukeepaisarnjaroen, W Chao, Y Yen, CJ Lausoontornsiri, W Chen, PJ Sanpajit, T Camp, A Cox, DS Gagnon, RC Liu, Y Raffensperger, KE Kulkarni, DA Kallender, H Ottesen, LH Poon, RTP Bottaro, DP |
2017 |
Clinical cancer research : an official journal of the American Association for Cancer Research 10 (23), pp. 2405-2413 |
|
| 24. | Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients. | Höner Zu Siederdissen, C Hui, AJ Sukeepaisarnjaroen, W Tangkijvanich, P Su, WW Nieto, GEG Gineste, P Nitcheu, J Crabé, S Stepien, S Manns, MP Trépo, C Wedemeyer, H Cornberg, M |
2018 |
The Journal of infectious diseases 9 (218), pp. 1480-1484 |
|
| 25. | A Hospital-Based Study of Intestinal Capillariasis in Thailand: Clinical Features, Potential Clues for Diagnosis, and Epidemiological Characteristics of 85 Patients. | Sadaow, L Sanpool, O Intapan, PM Sukeepaisarnjaroen, W Prasongdee, TK Maleewong, W |
2018 |
The American journal of tropical medicine and hygiene 1 (98), pp. 27-31 |
|
| 26. | Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study. | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Treeprasertsuk, S Tanwandee, T Charatcharoenwitthaya, P Thongsawat, S Leerapun, A Piratvisuth, T Boonsirichan, R Bunchorntavakul, C Pattanasirigool, C Pornthisarn, B Tuntipanichteerakul, S Sripariwuth, E Jeamsripong, W Sanpajit, T Poovorawan, Y Komolmit, P |
2018 |
Antiviral therapy 1 (23), pp. 67-75 |
|
| 27. | Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma. | Lim, HY Merle, P Weiss, KH Yau, T Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM |
2018 |
Clinical cancer research : an official journal of the American Association for Cancer Research 19 (24), pp. 4650-4661 |
|
| 28. | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. | Qin, S Chan, SL Sukeepaisarnjaroen, W Han, G Choo, SP Sriuranpong, V Pan, H Yau, T Guo, Y Chen, M Ren, Z Xu, J Yen, CJ Lin, ZZ Manenti, L Gu, Y Sun, Y Tiedt, R Hao, L Song, W Tanwandee, T |
2019 |
Therapeutic advances in medical oncology (11), pp. 1758835919889001 |
|
| 29. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients. | Sawadpanich, K Soison, P Chunlertrith, K Mairiang, P Sukeepaisarnjaroen, W Sangchan, A Suttichaimongkol, T Foocharoen, C |
2019 |
International journal of rheumatic diseases 4 (22), pp. 695-699 |
|
| 30. | Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Treeprasertsuk, S Tanwandee, T Charatcharoenwitthaya, P Thongsawat, S Leerapun, A Piratvisuth, T Boonsirichan, R Bunchorntavakul, C Pattanasirigool, C Pornthisarn, B Tuntipanichteerakul, S Sripariwuth, E Jeamsripong, W Sanpajit, T Poovorawan, Y Komolmit, P |
2019 |
Asian Pacific journal of cancer prevention : APJCP 4 (20), pp. 1257-1264 |
|
| 31. | Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. | Thanapirom, K Suksawatamnuay, S Sukeepaisarnjaroen, W Tangkijvanich, P Thaimai, P Wasitthankasem, R Poovorawan, Y Komolmit, P |
2019 |
PeerJ (7), pp. e7666 |
|
| 32. | Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study. | Charatcharoenwitthaya, P Wongpaitoon, V Komolmit, P Sukeepaisarnjaroen, W Tangkijvanich, P Piratvisuth, T Sanpajit, T Sutthivana, C Bunchorntavakul, C Sobhonslidsuk, A Chonprasertsuk, S Siripipattanamongkol, C Sethasine, S Tanwandee, T , |
2020 |
BMC gastroenterology 1 (20), pp. 47 |
|
| 33. | Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients. | Sripongpun, P Tangkijvanich, P Chotiyaputta, W Charatcharoenwitthaya, P Chaiteerakij, R Treeprasertsuk, S Bunchorntavakul, C Sobhonslidsuk, A Leerapun, A Khemnark, S Poovorawan, K Siramolpiwat, S Chirapongsathorn, S Pan-Ngum, W Soonthornworasiri, N Sukeepaisarnjaroen, W , |
2020 |
JGH open : an open access journal of gastroenterology and hepatology 1 (4), pp. 69-74 |
|
| 34. | Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. | Gane, EJ Charlton, MR Mohamed, R Sollano, JD Tun, KS Pham, TTT Payawal, DA Gani, RA Muljono, DH Acharya, SK Zhuang, H Shukla, A Madan, K Saraf, N Tyagi, S Singh, KR Cua, IHY Jargalsaikhan, G Duger, D Sukeepaisarnjaroen, W Purnomo, HD Hasan, I Lesmana, LA Lesmana, CRA Kyi, KP Naing, W Ravishankar, AC Hadigal, S |
2020 |
Journal of viral hepatitis 5 (27), pp. 466-475 |
|
| 35. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. | Sandusadee, N Sukeepaisarnjaroen, W Suttichaimongkol, T |
2020 |
Heliyon 4 (6), pp. e03767 |
|
| 36. | An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. | Charlton, MR Alam, A Shukla, A Dashtseren, B Lesmana, CRA Duger, D Payawal, DA Duy Cuong, D Jargalsaikhan, G Cua, IHY Sollano, JD Singh, KR Madan, K Win, KM Kyi, KP Tun, KS Salih, M Rastogi, M Saraf, N Thuy, PTT Hien, PTD Gani, RA Mohamed, R Tanwandee, T Piratvisuth, T Sukeepaisarnjaroen, W Naing, W Hashmi, ZY |
2020 |
Journal of gastroenterology 9 (55), pp. 811-823 |
|
| 37. | What are the strongest indicators of intracerebral hemorrhage in mild traumatic brain injury? | Teeratakulpisarn, P Angkasith, P Wannakul, T Tanmit, P Prasertcharoensuk, S Thanapaisal, C Wongkonkitsin, N Kitkhuandee, A Sukeepaisarnjaroen, W Phuttharak, W Sawanyawisuth, K |
2021 |
Trauma surgery & acute care open 1 (6), pp. e000717 |
|
| 38. | Tongdee, S Sawunyavisuth, B Sukeepaisarnjaroen, W Boonsawat, W Khamsai, S Sawanyawisuth, K |
2021 |
Drug target insights (15), pp. 21-25 |
||
| 39. | Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study. | Ma, H Lim, TH Leerapun, A Weltman, M Jia, J Lim, YS Tangkijvanich, P Sukeepaisarnjaroen, W Ji, Y Le Bert, N Li, D Zhang, Y Hamatake, R Tan, N Li, C Strasser, SI Ding, H Yoon, JH Stace, NH Ahmed, T Anderson, DE Yan, L Bertoletti, A Zhu, Q Yuen, MF |
2021 |
JHEP reports : innovation in hepatology 6 (3), pp. 100361 |
|
| 40. | Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program. | Suttichaimongkol, T Rattananukrom, C Wongsaensook, A Sawanyawisuth, K Sukeepaisarnjaroen, W |
2021 |
Germs 3 (11), pp. 403-407 |
|
| 41. | Prevalence and factors correlated with hypertension secondary from obstructive sleep apnea. | Khamsai, S Mahawarakorn, P Limpawattana, P Chindaprasirt, J Sukeepaisarnjaroen, W Silaruks, S Senthong, V Sawunyavisuth, B Sawanyawisuth, K |
2021 |
Multidisciplinary respiratory medicine 1 (16), pp. 777 |
|
| 42. | Hypertensive crisis in patients with obstructive sleep apnea-induced hypertension. | Khamsai, S Chootrakool, A Limpawattana, P Chindaprasirt, J Sukeepaisarnjaroen, W Chotmongkol, V Silaruks, S Senthong, V Sittichanbuncha, Y Sawunyavisuth, B Sawanyawisuth, K |
2021 |
BMC cardiovascular disorders 1 (21), pp. 310 |
|
| 43. | Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B. | Yuen, MF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, YS Kim, YJ Poovorawan, K Tangkijvanich, P Schwabe, C Eley, T Brown, J Lee, ACH Thi, EP Paratala, B Mani, N Sofia, MJ Picchio, G Sims, KD Gane, EJ |
2022 |
Hepatology communications 12 (6), pp. 3457-3472 |
|
| 44. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. | Kelley, RK Rimassa, L Cheng, AL Kaseb, A Qin, S Zhu, AX Chan, SL Melkadze, T Sukeepaisarnjaroen, W Breder, V Verset, G Gane, E Borbath, I Rangel, JDG Ryoo, BY Makharadze, T Merle, P Benzaghou, F Banerjee, K Hazra, S Fawcett, J Yau, T |
2022 |
The Lancet. Oncology 8 (23), pp. 995-1008 |
|
| 45. | A surveillance for hepatitis C virus infection in northeastern, Thailand: a 10-year cohort. | Suttichaimongkol, T Rattananukrom, C Wongsaensook, A Sukeepaisarnjaroen, W Sawanyawisuth, K |
2022 |
Journal of preventive medicine and hygiene 2 (63), pp. E288-E291 |
|
| 46. | Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. | Malik, J Klammer, M Rolny, V Chan, HL Piratvisuth, T Tanwandee, T Thongsawat, S Sukeepaisarnjaroen, W Esteban, JI Bes, M Köhler, B Swiatek-de Lange, M |
2022 |
World journal of gastroenterology 29 (28), pp. 3917-3933 |
|
| 47. | Evaluation of total immunoglobulin G and subclass antibodies in an enzyme-linked immunosorbent assay for serodiagnosis of human amebic liver abscess. | Janwan, P Sadaow, L Rodpai, R Yamasaki, H Luvira, V Sukeepaisarnjaroen, W Kitkhuandee, A Paonariang, K Sanpool, O Boonroumkaew, P Thanchomnang, T Mita, T Intapan, PM Maleewong, W |
2022 |
PeerJ (10), pp. e14085 |
|
| 48. | High Prevalence of Intestinal Capillariasis in Chronic Diarrhea Patients in Thailand: Serological Screening Using a Rapid Lateral-Flow Immunochromatographic Assay. | Prasongdee, TK Seesui, K Sadee, P Sadaow, L Sukeepaisarnjaroen, W Kraiklang, R Sanpool, O Maleewong, W Intapan, PM |
2022 |
The American journal of tropical medicine and hygiene 2 (107), pp. 370-2 |
|
| 49. | Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study. | Teerasarntipan, T Thanapirom, K Chirapongsathorn, S Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 |
PloS one 11 (17), pp. e0277959 |
|
| 50. | Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis. | Rodpai, R Luvira, V Sadaow, L Sukeepaisarnjaroen, W Kitkhuandee, A Paonariang, K Sanpool, O Ittiprasert, W Mann, VH Intapan, PM Brindley, PJ Maleewong, W |
2022 |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (116), pp. 80-84 |
|
| 51. | Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter. | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2022 |
Future science OA 4 (8), pp. FSO785 |
|
| 52. | Oxygen saturation is associated with recurrent primary spontaneous pneumothorax treated by intercostal chest drainage. | Namwaing, P Chaisuksant, S Sawadpanich, R Anukunananchai, T Timinkul, A Sakaew, W Sawunyavisuth, B Sukeepaisarnjaroen, W Khamsai, S Sawanyawisuth, K |
2022 |
Asian journal of surgery 1 (45), pp. 431-434 |
|
| 53. | Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study. | Piratvisuth, T Tanwandee, T Thongsawat, S Sukeepaisarnjaroen, W Esteban, JI Bes, M Köhler, B He, Y Swiatek-de Lange, M Morgenstern, D Chan, HL |
2022 |
Hepatology communications 4 (6), pp. 679-691 |
|
| 54. | Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population. | Chirapongsathorn, S Teerasarntipan, T Tipchaichatta, K Suttichaimongkol, T Chamroonkul, N Bunchorntavakul, C Siramolpiwat, S Chainuvati, S Sobhonslidsuk, A Leerapun, A Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Treeprasertsuk, S |
2022 |
JGH open : an open access journal of gastroenterology and hepatology 3 (6), pp. 205-212 |
|
| 55. | Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease. | Tangvoraphonkchai, K Suttichaimongkol, T Kularbkaew, C Sangaimwibool, P Sukeepaisarnjaroen, W |
2022 |
Scientific reports 1 (12), pp. 6757 |
|
| 56. | Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand. | Dilokthornsakul, P Sawangjit, R Tangkijvanich, P Chayanupatkul, M Tanwandee, T Sukeepaisarnjaroen, W Sriuttha, P Permsuwan, U |
2022 |
Applied health economics and health policy 4 (20), pp. 587-596 |
|
| 57. | Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer). | Abou-Alfa, GK Lau, G Kudo, M Chan, SL Kelley, RK Furuse, J Sukeepaisarnjaroen, W Kang, YK Dao, TV De Toni, EN Rimassa, L Breder, V Vasilyev, A Heurgué, A Tam, VC Mody, K Thungappa, SC Ostapenko, Y Yau, T Azevedo, S Varela, M Cheng, AL Qin, S Galle, PR Ali, S Gupta, C Makowsky, M Kurland, JF Negro, A Sangro, B |
2023 |
Future oncology (London, England) 38 (19), pp. 2505-2516 |
|
| 58. | First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection. | Gane, EJ Kim, W Lim, TH Tangkijvanich, P Yoon, JH Sievert, W Sukeepaisarnjaroen, W Thompson, AJ Pavlovic, V Surujbally, B Wat, C Brown, BD Achneck, HE Yuen, MF |
2023 |
Journal of hepatology 5 (79), pp. 1139-1149 |
|
| 59. | Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | Do, WL Wang, L Forgues, M Liu, J Rabibhadana, S Pupacdi, B Zhao, Y Gholian, H Bhudhisawasdi, V Pairojkul, C Sukeepaisarnjaroen, W Pugkhem, A Luvira, V Lertprasertsuke, N Chotirosniramit, A Auewarakul, CU Ungtrakul, T Sricharunrat, T Sangrajrang, S Phornphutkul, K Budhu, A Harris, CC Mahidol, C Ruchirawat, M Wang, XW |
2023 |
Cell reports. Medicine 12 (4), pp. 101328 |
|
| 60. | Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. | Kohansal-Nodehi, M Swiatek-de Lange, M Kroeniger, K Rolny, V Tabarés, G Piratvisuth, T Tanwandee, T Thongsawat, S Sukeepaisarnjaroen, W Esteban, JI Bes, M Köhler, B Chan, HL Busskamp, H |
2023 |
Frontiers in oncology (13), pp. 1213898 |
|
| 61. | Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry. | Chirapongsathorn, S Sukeepaisarnjaroen, W Treeprasertsuk, S Chaiteerakij, R Surawongsin, P Hongthanakorn, C Siramolpiwat, S Chamroonkul, N Bunchorntavakul, C Chotiyaputta, W Poovorawan, K Boonsirichan, R Lawpoolsri, S Sutivana, C Sobhonslidsuk, A |
2023 |
Journal of clinical and translational hepatology 1 (11), pp. 88-96 |
|
| 62. | PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. | Suttichaimongkol, T Mitpracha, M Tangvoraphonkchai, K Sadee, P Sawanyawisuth, K Sukeepaisarnjaroen, W |
2023 |
Journal of circulating biomarkers (12), pp. 12-16 |
|
| 63. | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. | Sangro, B Chan, SL Kelley, RK Lau, G Kudo, M Sukeepaisarnjaroen, W Yarchoan, M De Toni, EN Furuse, J Kang, YK Galle, PR Rimassa, L Heurgué, A Tam, VC Van Dao, T Thungappa, SC Breder, V Ostapenko, Y Reig, M Makowsky, M Paskow, MJ Gupta, C Kurland, JF Negro, A Abou-Alfa, GK , |
2024 |
Annals of oncology : official journal of the European Society for Medical Oncology 5 (35), pp. 448-457 |
|
| 64. | Pooled prevalences of obstructive sleep apnea and heart failure: a systematic review and meta-analysis. | Prechaporn, W Hantrakul, P Ngamjarus, C Sukeepaisarnjaroen, W Sawanyawisuth, K Khamsai, S |
2024 |
Heart failure reviews 4 (29), pp. 811-826 |
|
| 65. | The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand. | Pupacdi, B Loffredo, CA Budhu, A Rabibhadana, S Bhudhisawasdi, V Pairojkul, C Sukeepaisarnjaroen, W Pugkhem, A Luvira, V Lertprasertsuke, N Chotirosniramit, A Auewarakul, CU Ungtrakul, T Sricharunrat, T Sangrajrang, S Phornphutkul, K Albert, PS Kim, S Harris, CC Mahidol, C Wang, XW Ruchirawat, M , |
2024 |
International journal of cancer 8 (155), pp. 1387-1399 |
|
| 66. | Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. | Toyoda, H Kanneganti, M Melendez-Torres, J Parikh, ND Jalal, PK Piñero, F Mendizabal, M Ridruejo, E Cheinquer, H Casadei-Gardini, A Weinmann, A Peck-Radosavljevic, M Dufour, JF Radu, P Shiha, G Soliman, R Sarin, SK Kumar, M Wang, JH Tangkijvanich, P Sukeepaisarnjaroen, W Atsukawa, M Uojima, H Nozaki, A Nakamuta, M Takaguchi, K Hiraoka, A Abe, H Matsuura, K Watanabe, T Shimada, N Tsuji, K Ishikawa, T Mikami, S Itobayashi, E Singal, AG Johnson, PJ |
2024 |
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 1 (22), pp. 72-80.e4 |
|
| 67. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study. | Yau, T Kaseb, A Cheng, AL Qin, S Zhu, AX Chan, SL Melkadze, T Sukeepaisarnjaroen, W Breder, V Verset, G Gane, E Borbath, I Rangel, JDG Ryoo, BY Makharadze, T Merle, P Benzaghou, F Milwee, S Wang, Z Curran, D Kelley, RK Rimassa, L |
2024 |
The lancet. Gastroenterology & hepatology 4 (9), pp. 310-322 |
|
| 68. | Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand. | Sriphoosanaphan, S Pantumongkol, W Kulpeng, W Charonpongsuntorn, C Tanwandee, T Sukeepaisarnjaroen, W Sobhonslidsuk, A Tangkijvanich, P |
2024 |
PloS one 3 (19), pp. e0300327 |
|
| 69. | A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis. | Köhler, B Bes, M Chan, HL Esteban, JI Piratvisuth, T Sukeepaisarnjaroen, W Tanwandee, T Thongsawat, S Mang, A Morgenstern, D Swiatek-de Lange, M Dayyani, F |
2024 |
The International journal of biological markers (), pp. 3936155241235185 |
|
| 70. | Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. | Lau, G Abou-Alfa, GK Cheng, AL Sukeepaisarnjaroen, W Van Dao, T Kang, YK Thungappa, SC Kudo, M Sangro, B Kelley, RK Furuse, J Park, JW Sunpaweravong, P Fasolo, A Yau, T Kawaoka, T Azevedo, S Reig, M Assenat, E Yarchoan, M He, AR Makowsky, M Gupta, C Negro, A Chan, SL |
2025 |
Journal of hepatology 2 (82), pp. 258-267 |
|
| 71. | Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma. | Sadaow, L Rodpai, R Smout, MJ Nakajima, R Boonroumkaew, P Sotillo, J Tedla, BA Luvira, V Kitkhuandee, A Paonariang, K Sukeepaisarnjaroen, W Yamasaki, H Suttiprapa, S Laha, T Sripa, B de Assis, R Jain, A Ittiprasert, W Mann, VH Wong, Y Felgner, PL Maleewong, W Brindley, PJ Loukas, A Intapan, PM |
2025 |
Nature communications 1 (16), pp. 5965 |
|
| 72. | Differential diagnosis of ulcers throughout the colon. | Deesomsak, M Sukeepaisarnjaroen, W Sawanyawisuth, K |
Revista da Sociedade Brasileira de Medicina Tropical 3 (47), pp. 401 |
||
| 73. | GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis. | Chunlertrith, K Noiprasit, A Foocharoen, C Mairiang, P Sukeepaisarnjaroen, W Sangchan, A Sawadpanitch, K |
Clinical and experimental rheumatology 6 (32), pp. S-98-102 |
||
| 74. | Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding. | Sukeepaisarnjaroen, W Sawanyawisuth, K |
Tropical gastroenterology : official journal of the Digestive Diseases Foundation 4 (35), pp. 260-1 |
||
| 75. | Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy. | Sukeepaisarncharoen, W Churdboonchart, V Kulpradist, S Isarangkura Na Ayudthya, B Rugpao, S Chandeying, V Sirawaraporn, W Carlo, D Moss, RB |
HIV clinical trials 5 (2), pp. 391-8 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000) | V Churdboonchart C Sakondhavat S Kulpradist BIN Ayudthya V Chandeying S Rugpao C Boonshuyar W Sukeepaisarncharoen W Sirawaraporn DJ Carlo R Moss |
2001 |
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 6.0 (8.0), pp. 1295.0-1295.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2. | Effectiveness of remune - Authors' reply | V Churdboonchart W Sirawaraporn C Boonshuyar C Sakondhavat W Sukeepaisarncharoen S Kulpradist BIN Ayudthya V Chandeying S Rugpao |
2001 |
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 2.0 (8.0), pp. 469.0-469.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Delayed progression to AIDS in volunteers treated with long-term HIV-1 immunogen (REMUNE (R)) therapy in Thailand | W Chantratita W Sukeepaisarncharoen V Chandeying S Kulpradist BIN Ayudhtaya S Rugpao W Sirawaraporn C Boonshuyar V Churdboonchart |
2004 |
HIV MEDICINE 5.0 (5.0), pp. 317.0-325.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 4. | Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis | PM Intapan W Maleewong W Sukeepaisarnjaroen N Morakote |
2006 |
PARASITOLOGY RESEARCH 3.0 (98.0), pp. 227.0-231.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 5. | AN ENZYME-LINKED IMMUNOSORBENT ASSAY AS SCREENING TOOL FOR HUMAN INTESTINAL CAPILLARIASIS | Pewpan M. Intapan Wanchai Maleewong Watana Sukeepaisarnjaroen Nimit Morakote |
2010 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 2.0 (41.0), pp. 298.0-305.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 6. | Biliary Ascariasis After Worm Removal from the Duodenum and Single-Dose Albendazole Treatment | Arthit Wongsaensook Wattana Sukeepaisarnjaroen Kittisak Sawanyawisuth |
2010 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 1.0 (83.0), pp. 7.0-8.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY | G. Foster R. Flisiak W. -L. Chuang J. George J. Rasenack A. Sood P. Komolmit S. Thongsawat T. Tanwandee R. Sola W. Sukeepaisarnjaroen M. Weltman Y. Yin G. Feutren K. Brown |
2011 |
JOURNAL OF HEPATOLOGY (54.0), pp. S171-S172 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS | T. Piratvisuth P. Komolmit T. Tanwandee W. Sukeepaisarnjaroen H. L. Chan M. G. Pessoa E. Fassio S. Ono-Nita F. Bessone J. Daruich S. Zeuzem H. Cheinquer Y. Dong A. Trylesinski |
2012 |
JOURNAL OF HEPATOLOGY (56.0), pp. S214-S214 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 9. | A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). | Thomas Cheung Yau Wattana Sukeepaisarnjaroen Yee Chao Chia-Jui Yen Wirote Lausoontornsiri Pei-Jer Chen Theeranun Sanpajit Riccardo Lencioni Aaron C. Camp Donna S. Cox Howard Kallender Lone Harild Ottesen Ronnie Tung-Ping Poon |
2012 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (30.0), pp. |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 10. | 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B | Teerha Piratvisuth Piyawat Komolmit Tawesak Tanwandee Wattana Sukeepaisarnjaroen Henry L. Y. Chan Mario G. Pessoa Eduardo Fassio Suzane K. Ono Fernando Bessone Jorge Daruich Stefan Zeuzem Hugo Cheinquer Rashidkhan Pathan Yuhong Dong Aldo Trylesinski |
2013 |
PLOS ONE 2.0 (8.0), pp. |
35 | 0 | 0 | 0 | 0 | 0 | 35 | |
| 11. | Differential diagnosis of ulcers throughout the colon | Morakod Deesomsak Wattana Sukeepaisarnjaroen Kittisak Sawanyawisuth |
2014 |
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL 3.0 (47.0), pp. 401.0-401.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Final results of Boceprevir Early-Access For Advanced Fibrosis/Cirrhosis In Asia-Pacific HCV Genotype 1 Non-Responders/Relapser Patients (Beacon Study) | Wattana Sukeepaisarnjaroen Tri H. Pham Tawesak Tanwandee Saroja Nazareth Sam Galhenage Lindsay Mollison Leanne Totten Alan J. Wigg Rosalie Altus Anton Colman Brenda Morales Susan Mason Tracey L. Jones Nadine Leembruggen Vince Fragomelli Cheryl Sendall Richard Guan Dede Sutedja Soek Siam Tan Yock Young Dan Yin-Mei Lee Widjaja Luman Eng Kiong Teo Yin Min Than Teerha Piratvisuth Seng Gee Lim |
2014 |
HEPATOLOGY (60.0), pp. 698A-698A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Genetic Variation in Vitamin D Pathway DHCR7 Gene Predicts Poor Response to Pegylated Interferon-Alfa Based Therapy in Asian Chronic Hepatitis C Genotype 1-Infected Patients | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Panarat Thaimai Warattaya Sukkharin Srunthron Akkarathamrongsin Yong Poovorawan Pinit Kullavanijaya Piyawat Komolmit |
2014 |
GASTROENTEROLOGY 5.0 (146.0), pp. S967-S967 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis | K. Chunlertrith A. Noiprasit C. Foocharoen P. Mairiang W. Sukeepaisarnjaroen A. Sangchan K. Sawadpanitch |
2014 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 6.0 (32.0), pp. S98-S102 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 15. | The Association of the CXCL10, Dpp-4 Gene Polymorphisms and Complementary Role for Unfavorable IL-28B Genotype in Prediction of Treatment Response in Asian Patients With Chronic Hepatitis C Virus Infection | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Panarat Thaimai Warattaya Sukkharin Srunthron Akkarathamrongsin Yong Poovorawan Pinit Kullavanijaya Piyawat Komolmit |
2014 |
GASTROENTEROLOGY 5.0 (146.0), pp. S965-S965 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16. | VITAMIN D RELATED PATHWAY GENE POLYMORPHISMS ENHANCED THE PREDICTION OF TREATMENT RESPONSE IN ASIAN CHRONIC HEPATITIS C-INFECTED PATIENTS WITH UNFAVORABLE IL-28B rs12979860 GENOTYPES | K. Thanapirom S. Suksawatamnuay W. Sukeepaisarnjaroen P. Tangkijvanich S. Treeprasertsuk P. Thaimai S. Akkarathamrongsin Y. Poovorawan P. Kullavanijaya P. Komolmit |
2014 |
JOURNAL OF HEPATOLOGY 1.0 (60.0), pp. S319-S320 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Sombat Treeprasertsuk Panarat Thaimai Rujipat Wasitthankasem Yong Poovorawan Piyawat Komolmit |
2015 |
PLOS ONE 9.0 (10.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 18. | Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers | Wattana Sukeepaisarnjaroen Tri Pham Tewesak Tanwandee Saroja Nazareth Sam Galhenage Lindsay Mollison Leanne Totten Alan Wigg Rosalie Altus Anton Colman Brenda Morales Sue Mason Tracey Jones Nadine Leembruggen Vince Fragomelli Cheryl Sendall Richard Guan Dede Sutedja Soek Siam Tan Yock Young Dan Yin Mei Lee Widjaja Luman Eng Kiong Teo Yin Min Than Teerha Piratvisuth Seng Gee Lim |
2015 |
WORLD JOURNAL OF GASTROENTEROLOGY 28.0 (21.0), pp. 8660.0-8669.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 19. | Genetic Variation in Vitamin D Pathway CYP2R1 gene predict sustained HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon: Multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Kittiyod Poovorawan Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 |
HEPATOLOGY (62.0), pp. 1004A-1004A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | Phase II study of front-line dovitinib (TKI258) versus sorafenib in patients (Pts) with advanced hepatocellular carcinoma (HCC) | Ann-Lii Cheng Sumitra Thongprasert Ho Yeong Lim Wattana Sukeepaisarnjaroen Tsai-Sheng Yang Cheng-Chung Wu Yee Chao Stephen Lam Chan Masatoshi Kudo Masafumi Ikeda Yoon-Koo Kang Hongming Pan Kazushi Numata Guohong Han Binaifer Balsara Yong Zhang Ana-Maria Rodriguez Yi Zhang Yongyu Wang Ronnie Tung-Ping Poon |
2015 |
JOURNAL OF CLINICAL ONCOLOGY 3.0 (33.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 21. | The Association of vitamin D metabolic pathway related genes polymorphisms with virologic response in HBeAg-negative patients treated with pegylated interferon: Multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 |
HEPATOLOGY (62.0), pp. 1019A-1019A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | The Single Nucleotide Polymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B Patients Treated With Pegylated Interferon: Multicenter Study | Kessarin Thanapirom Sirinporn Suksawatamnuay Kittiyod Poovorawan Wattana Sukeepaisarnjaroen Tawesak Tanwandee Satawat Thongsawat Apinya Leerapun Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Piyawat Komolmit |
2015 |
GASTROENTEROLOGY 4.0 (148.0), pp. S1066-S1066 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | A phase (Ph) II study of the efficacy and safety of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced hepatocellular carcinoma (HCC) | Tawesak Tanwandee Wattana Sukeepaisarnjaroen Stephen Lam Chan SuPin Choo Guohong Han Virote Sriuranpong Hongming Pan Thomas Cheung Yau Zhenggang Ren Jian-Ming Xu Bin Peng Takami Saji Yongjian Sun Alan Huang Luigi Manenti Shukui Qin |
2016 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (34.0), pp. |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 24. | Cost utility analysis of palliative biliary drainage compare with palliative care in unresectable hilar cholangiocarcinoma | Schlermbhol Borntrakulpipat Apichat Sangchan Pisaln Mairiang Eimorn Mairiang Wattana Sukeepaisarnjaroen Kitti Chunlertrith Kookwan Sawadpanitch Tanita Suttichaimongkol Yupa Thawornpitak |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 228.0-229.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 25. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 78.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma | Ann-Lii Cheng Sumitra Thongprasert Ho Yeong Lim Wattana Sukeepaisarnjaroen Tsai-Shen Yang Cheng-Chung Wu Yee Chao Stephen L. Chan Masatoshi Kudo Masafumi Ikeda Yoon-Koo Kang Hongming Pan Kazushi Numata Guohong Han Binaifer Balsara Yong Zhang Ana-Marie Rodriguez Yi Zhang Yongyu Wang Ronnie T. P. Poon |
2016 |
HEPATOLOGY 3.0 (64.0), pp. 774.0-784.0 |
52 | 0 | 0 | 0 | 0 | 0 | 52 | |
| 27. | The association of S267F variant on NTCP (SLC10A1), a hepatitis B viral surface receptor, and treatment response with pegylated interferon in chronic hepatitis B patients: a multicenter study | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Tawesak Tanwandee Phunchai Charatcharoenwitthaya Satawat Thongsawat Apinya Leerapun Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supot Tantipanichtheerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Yong Poovorawan Piyawat Komolmit |
2016 |
HEPATOLOGY (64.0), pp. 291A-291A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 28. | Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study | Phunchai Charatcharoenwitthaya Wattana Sukeepaisarnjaroen Teerha Piratvisuth Satawat Thongsawat Theeranun Sanpajit Soonthorn Chonprasertsuk Woramon Jeamsripong Ekawee Sripariwuth Piyawat Komolmit Tanisa Patcharatrakul Rattana Boonsirichan Chalermrat Bunchorntavakul Supoj Tuntipanichteerakul Tawesak Tanwandee |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 11.0 (31.0), pp. 1874.0-1881.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 29. | A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma | Thomas C. C. Yau Riccardo Lencioni Wattana Sukeepaisarnjaroen Yee Chao Chia-Jui Yen Wirote Lausoontornsiri Pei-Jer Chen Theeranun Sanpajit Aaron Camp Donna S. Cox Robert C. Gagnon Yuan Liu Kristen E. Raffensperger Diptee A. Kulkarni Howard Kallender Lone Harild Ottesen Ronnie T. P. Poon Donald P. Bottaro |
2017 |
CLINICAL CANCER RESEARCH 10.0 (23.0), pp. 2405.0-2413.0 |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
| 30. | Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjects | T. Tanwandee S. Chatsiricharoenkul S. Thongsawat W. Sukeepaisarnjaroen P. Tangkijvanich P. Komolmit A. Avihingsanon T. Piratvisuth P. Sunthi T. Mahasanprasert T. Matkovits M. Conover J. Cobb C. Canizares J. Sullivan-Bolyai |
2017 |
JOURNAL OF HEPATOLOGY 1.0 (66.0), pp. S24-S25 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 31. | Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses | Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Piyawat Komolmit Anchalee Avihingsanon Teerha Piratvisuth |
2017 |
HEPATOLOGY (66.0), pp. 505A-505A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 32. | Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir | H. Wedemeyer A. J. Hui W. Sukeepaisarnjaroen P. Tangkijvanich W. W. Su G. E. G. Nieto P. Gineste J. Nitcheu S. Crabe S. Stepien M. Cornberg C. Trepo |
2017 |
JOURNAL OF HEPATOLOGY 1.0 (66.0), pp. S101-S101 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 33. | Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Sombat Treeprasertsuk Panarat Thaimai Rujipat Wasitthankasem Yong Poovorawan Piyawat Komolmit |
2017 |
BMC GASTROENTEROLOGY (17.0), pp. |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 34. | A Hospital-Based Study of Intestinal Capillariasis in Thailand: Clinical Features, Potential Clues for Diagnosis, and Epidemiological Characteristics of 85 Patients | Lakkhana Sadaow Oranuch Sanpool Pewpan M. Intapan Wattana Sukeepaisarnjaroen Thidarat K. Prasongdee Wanchai Maleewong |
2018 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 1.0 (98.0), pp. 27.0-31.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 35. | Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Sombat Treeprasertsuk Tawesak Tanwandee Phunchai Charatcharoenwitthaya Satawat Thongsawat Apinya Leerapun Teerha Piratvisuth Rattana Boonsirichan Chalermrat Bunchorntavakul Chaowalit Pattanasirigool Bubpha Pornthisarn Supoj Tuntipanichteerakul Ekawee Sripariwuth Woramon Jeamsripong Theeranun Sanpajit Yong Poovorawan Piyawat Komolmit |
2018 |
ANTIVIRAL THERAPY 1.0 (23.0), pp. 67.0-75.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 36. | EVALUATION OF BEDSIDE BIOMARKERS APRI AND FIB4 SCORES FOR HEPATIC FIBROSIS ASSESSMENT COMPARED WITH TRANSIENT ELASTOGRAPHY (TE) IN CHRONIC HEPATITIS C PATIENTS | Pimsiri Sripongpun Pisit Tangkijvanich Roongruedee Chaiteerakij Kittiyod Poovorawan Abhasnee Sobhonslidsuk Chalermrat Bunchorntavakul Sakkarin Chirapongsathorn Sith Siramolpiwat Suparat Khemnark Apinya Leerapun Sombat Treeprasertsuk Watcharasak Chotiyaputta Wirichada Pan-Ngum Ngamphol Soonthornworasiri Wattana Sukeepaisarnjaroen |
2018 |
GASTROENTEROLOGY 6.0 (154.0), pp. S1244-S1245 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 37. | Individualized cancer vaccine to elicit tumor debulking immunity in advanced HCC | Michael Har-Noy Wattana Sukeepaisarnjaroen Wirote Lausoontornsiri Aaron Wittenberg Miriam Bloch Tehila Sonnenfeld |
2018 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (36.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 38. | Personalized vaccine for advanced HCC. | Wirote Lausoontornsiri Michael Har-Noy Jitraporn Wongwiwatcha Miriam Bloch Supaporn Suparak Anucha Ahooja Michael Bishop Wattana Sukeepaisarnjaroen |
2018 |
JOURNAL OF CLINICAL ONCOLOGY 4.0 (36.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 39. | Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma | Ho Yeong Lim Philippe Merle Karl Heinz Weiss Thomas Yau Paul Ross Vincenzo Mazzaferro Jean-Frederic Blanc Yuk Ting Ma Chia Jui Yen Judit Kocsis Su Pin Choo Wattana Sukeepaisarnjaroen Rene Gerolami Jean-Francois Dufour Edward J. Gane Baek-Yeol Ryoo Markus Peck-Radosavljevic Thong Dao Winnie Yeo Wisut Lamlertthon Satawat Thongsawat Michael Teufel Katrin Roth Diego Reis Barrett H. Childs Heiko Krissel Josep M. Llovet |
2018 |
CLINICAL CANCER RESEARCH 19.0 (24.0), pp. 4650.0-4661.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 40. | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | Shukui Qin Stephen Lam Chan Wattana Sukeepaisarnjaroen Guohong Han Su Pin Choo Virote Sriuranpong Hongming Pan Thomas Yau Yabing Guo Minshan Chen Zhenggang Ren Jianming Xu Chia-Jui Yen Zhong-Zhe Lin Luigi Manenti Yi Gu Yongjian Sun Ralph Tiedt Lu Hao Wenjie Song Tawesak Tanwandee |
2019 |
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (11.0), pp. |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 41. | Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C | Kessarin Thanapirom Sirinporn Suksawatamnuay Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Panarat Thaimai Rujipat Wasitthankasem Yong Poovorawan Piyawat Komolmit |
2019 |
PEERJ (7.0), pp. |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 42. | Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients | Kookwan Sawadpanich Pisit Soison Kitti Chunlertrith Pisaln Mairiang Wattana Sukeepaisarnjaroen Apichat Sangchan Tanita Suttichaimongkol Chingching Foocharoen |
2019 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (22.0), pp. 695.0-699.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 43. | PROGNOSTIC FACTORS FOR REMISSION, RELAPSE AND TREATMENT COMPLICATIONS OF TYPE 1 AUTOIMMUNE HEPATITIS IN THAILAND | Nitipat Sandusadee Tanita Suttichaimongkol Wattana Sukeepaisarnjaroen |
2019 |
GASTROENTEROLOGY 6.0 (156.0), pp. S1356-S1356 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 44. | SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND ANTIVIRAL ACTIVITY OF THE CAPSID INHIBITOR (CI) AB-506 IN HEALTHY SUBJECTS (HS) AND CHRONIC HEPATITIS B (CHB) SUBJECTS | Man-Fung Yuen Elina Berliba Wattana Sukeepaisarnjaroen Sang Hoon Ahn Tawesak Tanwandee Young-Suk Lim Yoon Jun Kim Kittiyod Poovorawan Pisit Tangkijvanich Henry Lik Yuen Chan Timothy Eley Joanne Brown Christopher Moore Amy C. H. Lee Jin Kim Emily P. Thi Nagraj Mani Rene Rijnbrand Andrew Cole Michael J. Sofia Gaston R. Picchio Karen Sims Edward J. Gane |
2019 |
HEPATOLOGY 6.0 (70.0), pp. 1492A-1493A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 45. | An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia | Michael R. Charlton Altaf Alam Akash Shukla Bekhbold Dashtseren Cosmas Rinaldi Adithya Lesmana Davadoorj Duger Diana Alcantara Payawal Do Duy Cuong Ganbolor Jargalsaikhan Ian Homer Yee Cua Jose Decena Sollano Karam Romeo Singh Kaushal Madan Khin Maung Win Khin Pyone Kyi Kyaw Soe Tun Mohd. Salih Mukul Rastogi Neeraj Saraf Pham Thi Thu Thuy Pham Tran Dieu Hien Rino Alvani Gani Rosmawati Mohamed Tawesak Tanwandee Teerha Piratvisuth Wattana Sukeepaisarnjaroen Win Naing Zahid Yasin Hashmi |
2020 |
JOURNAL OF GASTROENTEROLOGY 9.0 (55.0), pp. 811.0-823.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 46. | Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings | Edward John Gane Michael R. Charlton Rosmawati Mohamed Jose Decena Sollano Kyaw Soe Tun Thuy Thi Thu Pham Diana Alcantara Payawal Rino Alvani Gani David Handojo Muljono Subrat Kumar Acharya Hui Zhuang Akash Shukla Kaushal Madan Neeraj Saraf Satyendra Tyagi Karam Romeo Singh Ian Homer Yee Cua Ganbolor Jargalsaikhan Davadoorj Duger Wattana Sukeepaisarnjaroen Hery Djagat Purnomo Irsan Hasan Laurentius Adrianto Lesmana Cosmas Rinaldi Adithya Lesmana Khin Pyone Kyi Win Naing Allampura Chandrashekar Ravishankar Sanjay Hadigal |
2020 |
JOURNAL OF VIRAL HEPATITIS 5.0 (27.0), pp. 466.0-475.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 47. | Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients | Pimsiri Sripongpun Pisit Tangkijvanich Watcharasak Chotiyaputta Phunchai Charatcharoenwitthaya Roongruedee Chaiteerakij Sombat Treeprasertsuk Chalermrat Bunchorntavakul Abhasnee Sobhonslidsuk Apinya Leerapun Suparat Khemnark Kittiyod Poovorawan Sith Siramolpiwat Sakkarin Chirapongsathorn Wirichada Pan-Ngum Ngamphol Soonthornworasiri Wattana Sukeepaisarnjaroen |
2020 |
JGH OPEN 1.0 (4.0), pp. 69.0-74.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 48. | IDENTIFICATION OF MULTIMARKER PANELS FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA (HCC) THROUGH EXHAUSTIVE SEARCH | Henry Lik Yuen Chan Teerha Piratvisuth Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Juan Ignacio Esteban Mur Marta Bes Bruno Koehler Marcus-Rene Lisy Christine Belz Vinzent Rolny Magdalena Swiatek-De Lange Dave Morgenstern |
2020 |
HEPATOLOGY (72.0), pp. 680A-681A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 49. | ON-GOING REGISTRY TO UNDERSTAND PATIENT CHARACTERISTICS AND TREATMENT OUTCOMES IN ADULTS WITH CHRONIC HEPATITIS C INFECTION ACROSS ASIA AND AFRICA | Akash Shukla Asad Ali Choudhry Charles Onyekwere Hery Djagat Purnomo Karam Romeo Singh Kyaw Soe Tun Leolin Katsidzira Teerha Piratvisuth Umed Ismoilov Wattana Sukeepaisarnjaroen Zeeshan Ul Haque Sanjay Hadigal Gagan Dua Ravishankar Naidu |
2020 |
HEPATOLOGY (72.0), pp. 539A-540A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50. | Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis | Nitipat Sandusadee Wattana Sukeepaisarnjaroen Tanita Suttichaimongkol |
2020 |
HELIYON 4.0 (6.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 51. | Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study | Phunchai Charatcharoenwitthaya Virasak Wongpaitoon Piyawat Komolmit Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Teerha Piratvisuth Theeranun Sanpajit Chinnavat Sutthivana Chalermrat Bunchorntavakul Abhasnee Sobhonslidsuk Soonthorn Chonprasertsuk Chotipong Siripipattanamongkol Supatsri Sethasine Tawesak Tanwandee |
2020 |
BMC GASTROENTEROLOGY 1.0 (20.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 52. | Clinical factors predictive of appropriate treatment in COPD: a community hospital setting | Sukanya Tongdee Bundit Sawunyavisuth Wattana Sukeepaisarnjaroen Watchara Boonsawat Sittichai Khamsai Kittisak Sawanyawisuth |
2021 |
DRUG TARGET INSIGHTS (15.0), pp. 21.0-25.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 53. | Hypertensive crisis in patients with obstructive sleep apnea-induced hypertension | Sittichai Khamsai Apichart Chootrakool Panita Limpawattana Jarin Chindaprasirt Wattana Sukeepaisarnjaroen Verajit Chotmongkol Songkwan Silaruks Vichai Senthong Yuwares Sittichanbuncha Bundit Sawunyavisuth Kittisak Sawanyawisuth |
2021 |
BMC CARDIOVASCULAR DISORDERS 1.0 (21.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 54. | LOW HBsAg LEVELS MAINTAINED FOLLOWING CESSATION OF THE GALNAC-siRNA, AB-729, IN CHRONIC HEPATITIS B SUBJECTS ON NUCLEOS(T)IDE ANALOGUE THERAPY | Man Fung Yuen Elina Berliba Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Apinya Leerapun Jacinta A. Holmes Edward J. Gane Alina Jucov Emily P. Thi Michael J. Sofia Heather Sevinsky Timothy Eley Elina Medvedeva Kevin Gray Deana Antoniello Gaston R. Picchio Karen Sims Simone I. Strasser |
2021 |
HEPATOLOGY 6.0 (74.0), pp. 1402A-1403A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 55. | Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study | Teerha Piratvisuth Tawesak Tanwandee Satawat Thongsawat Wattana Sukeepaisarnjaroen Juan Ignacio Esteban Marta Bes Bruno Koehler Ying He Magdalena Swiatek-de Lange David Morgenstern Henry Lik-Yuen Chan |
2021 |
HEPATOLOGY COMMUNICATIONS (), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 56. | Restoration of HBV-specific immune responses with therapeutic vaccine BRII-179 (VBI-2601) in chronic HBV patients in a phase 1b/2a study | Haiyan Ma Tien Huey Lim Apinya Leerapun Martin Weltman Ji-Dong Jia Young-Suk Lim Pisit Tangkijvanich Wattana Sukeepaisarnjaroen Nina Le Bert Yun Ji Dong Li Yao Zhang Robert Hamatake Simone Strasser Chunming Li Huiguo Ding Jung-Hwan Yoon Stace Nigel David Anderson Li Yan Antonio Bertoletti Qing Zhu Man-Fung Yuen |
2021 |
JOURNAL OF HEPATOLOGY (75.0), pp. S731-S731 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 57. | Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program | Tanita Suttichaimongkol Chitchai Rattananukrom Arthit Wongsaensook Kittisak Sawanyawisuth Wattana Sukeepaisarnjaroen |
2021 |
GERMS 3.0 (11.0), pp. 403.0-407.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 58. | THE PHARMACOKINETIC AND SAFETY PROFILES OF RO7445482 siRNA ARE SIMILAR BETWEEN ASIAN AND NON-ASIAN HEALTHY VOLUNTEERS AND CHRONIC HEPATITIS B PATIENTS IN A PHASE 1 STUDY | Edward J. Gane Nelson Guerreiro Simon Buatois Won Kim Jung-Hwan Yoon Tien Huey Lim William Sievert Alexander Thompson Wattana Sukeepaisarnjaroen Pisit Tangkijvanich Christian Schwabe Bob D. Brown Miriam Triyatni Qingyan Bo Hardean Achneck Man-Fung Yuen |
2021 |
HEPATOLOGY (74.0), pp. 521A-521A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 59. | Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study | Haiyan Ma Tien Huey Lim Apinya Leerapun Martin Weltman Jidong Jia Young-Suk Lim Pisit Tangkijvanich Wattana Sukeepaisarnjaroen Yun Ji Nina Le Bert Dong Li Yao Zhang Robert Hamatake Nicole Tan Chunming Li Simone Strasser Huiguo Ding Jung-Hwan Yoon Nigel H. Stace Tanvir Ahmed Dave E. Anderson Li Yan Antonio Bertoletti Qing Zhu Man-Fung Yuen |
2021 |
JHEP REPORTS 6.0 (3.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 60. | What are the strongest indicators of intracerebral hemorrhage in mild traumatic brain injury? | Panu Teeratakulpisarn Phati Angkasith Thanakorn Wannakul Parichat Tanmit Supatcha Prasertcharoensuk Chaiyut Thanapaisal Narongchai Wongkonkitsin Amnat Kitkhuandee Wattana Sukeepaisarnjaroen Warinthorn Phuttharak Kittisak Sawanyawisuth |
2021 |
TRAUMA SURGERY & ACUTE CARE OPEN 1.0 (6.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Etiology of dyspepsia in Srinagarind Hospital : a prospective data analysis | Kitti Chunlertrith Pisaln Mairiang Wattana Sukeepaisarnjaroen Eimorn Mairiang Vallop Laopaiboon |
1990 |
Srinagarind Medical Journal (5 No 4), pp. 227-232 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|